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Exocytosis is a process used by many cells to move material out of the
cell. This process is used by nerve cells to communicate with one another at
synapses. This communication is achieved in part by the release of neurotrans-
mitters at the nerve terminal into the extracellular space. Neurotransmitters are
contained in membrane bound organelles called vesicles. These vesicles dock
and fuse with the plasma membrane of the cell, where a fusion pore is cre-
ated to allow for the diffusion of neurotransmitters into the extracellular space.
The study of exocytosis has led to the identification of the SNARE proteins, lo-
cated on the vesicle (v-SNARE) and on the plasma membrane (t-SNARE). The
v-SNARE and the t-SNARE form a tight complex that holds the vesicle close
to the cell plasma membrane. However, it is unclear whether the SNARE pro-
teins also participate in the creation the fusion pore. In this thesis, the role of the
v-SNARE protein, synaptobrevin-2 is explored, in particular the role of its trans-
membrane domain which is embedded into the vesicle membrane. It turns out
that the formation of the SNARE complex formed by the association of the v-
SNARE and the t-SNARE pulls the C-terminus of synaptobrevin into the vesicle
lipid membrane, and with this movement, it disrupts the membrane continuity
leading the formation of the fusion pore. In addition, the transmembrane do-
main of synaptobrevin-2 is located at the vincinity of the fusion pore during the
fusion pore expansion.
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CHAPTER 1
INTRODUCTION
Neuron to neuron communication is one of the most important activities
occurring in living animals. The main task of neurons is to transmit informa-
tion throughout our body. In order to achieve this task, the information needs
to travel within neurons and, from one neuron to the next. While the informa-
tion travels along a neuron in the form of electrical pulses called action poten-
tial, it is sent to the neighboring neuron by neurotransmitter molecules that are
released in one cell, diffuse through the extracellular space and stimulate the
next neuron. Before their release, neurotransmitters are generally encapsulated
inside small membrane bound packets, called vesicles. At the arrival of a stimu-
lus, these vesicles fuse with the nerve terminal’s plasma membrane and thereby
release their content into the extracellular space. This process is called exocytosis.
Neurotransmitters are therefore essential for all kinds of brain activities
such as memory, attention, mood and the coordination of voluntary movement,
hence it is important for our body to sustain its functionality. One example for
the consequence of a neurotransmitter deficiency is Parkison’s disease, a chronic
movement disorder, where the release of the neurotransmitter dopamine is pro-
foundly impaired.
The study of the exocytotic process has advanced the understanding of
the mechanism of neurosecretion. For example, it was found that a high con-
centration of calcium stimulates the fusion of vesicles in neurons. Furthermore
the proteins that mediate the fusion could be identified as members of the so-
called SNARE (Soluble N-ethylmaleimide-sensitive-factor Attachement protein
REceptor) family [31, 34].
A system widely used to study neuronal exocytosis is the chromaffin cell
from the adrenal gland [Fig 1.1]. Similar to neurons, this cell type also encom-
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passes vesicles that undergo calcium dependent exocytosis and the fusion of
their vesicles is also mediated by the neuronal SNAREs.
Figure 1.1: Electron Micrograph of a bovine chromaffin cell. The small dark dots
are the dense core vesicles, located in the cytoplasm (Horstmann and
Lindau, unpublished).
The SNARE proteins can be divided into two subgroups, the vesicle SNARE
(v-SNARE) found on the vesicle membrane and the target SNARE (t-SNARE)
located on the plasma membrane of the cell . The original SNARE hypothesis
stipulated that when a vesicle is near the cell membrane, the t-SNARE and the v-
SNARE paired up side by side in opposite directions to form a SNARE complex
that leads to the fusion of the vesicle [31]. However, when the crystal structure
of the complex was solved, it was observed that although the t-SNARE and the
v-SNARE fold into an helical bundle [Fig.1.2 A], they adopt a parallel orienta-
tion with respect to each other [38, 36, 20]. Nevertheless, numerous experiments
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have confirmed that the formation of the SNARE complex leads to exocytosis as
initially postulated. For example, when toxins are used that specifically cleave
the SNARE proteins, neuronal exocytosis is abolished [28, 23, 27, 17]. Addi-
tional evidence supporting the essential role of SNAREs in vesicle fusion also
comes from experiments showing that mice that are genetically deprived of one
of the SNARE proteins are deficient in exocytosis [7, 3, 32, 29, 42]. Based on
these observations, it was proposed that the SNAREs constitute the scaffold of
the fusion machinery. However the specifics of the mechanisms by which the
SNARE proteins mediate the fusion of vesicles is still not fully understood.
1.1 SNARE complex formation
The neuronal v-SNARE also called synaptobrevin has a SNARE motif that is
located in the cytosol and a transmembrane domain, which is anchored into the
lipid membrane of the vesicle. The t-SNARE on the other hand, is comprised
of syntaxin and SNAP-25. Syntaxin has a similar structure to that of synapto-
brevin with the exception that it is anchored to the plasma membrane of the
cell, whereas SNAP-25 is covalently attached to the lipid plasma membrane by
means of cysteine residues.
The SNARE complex is formed by a 4-α-helical bundle [38], where synap-
tobrevin and syntaxin each provide one helix, and SNAP-25 provides the re-
maining two [Fig.1.2]. The helices are aligned in such a way that the interacting
amino acids (between 60 to 70 amino acids) are grouped into layers [Fig.1.2 B]
[9].
To understand the steps leading to the formation of the SNARE complex,
Sørensen and coworkers investigated how the complex assembles by interfering
with its stability [33]. By introducing point mutations in layer 5 or 8 of the
3
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Figure 1.2: Crystal structure of the SNARE complex. (A,C) The complex is com-
posed of 4 helices, synaptobrevin-2 (blue), syntaxin-1A (red), and
SNAP-25 which provide an additional two strands (Sn1 and Sn2
in green) as seen in this backbone ribbons drawing of the SNARE
complex structure. (B) Structural alignments of the SNARE proteins
around the super helix axis (black). The layers (+8 to -7) was inferred
based on the virtual bonds between the helices [38]. (C) The parallel
arrangement of the SNARE proteins into the complex continues into
the lipid membrane [36]. (Modified Figures from [36] and [38]).
4
carboxyl-terminal of SNAP-25 helices [Fig.1.2 B] , they destabilized the helical
interaction within the complex and observed that these mutations slowed down
the kinetics of rapid exocytosis. However, when the mutations were located
at the amino terminal, the kinetics of rapid exocytosis was unchanged. This
suggests that the SNARE complex folds in two steps from the amino-terminal
to the carboxyl (C)- terminal .
The SNARE complex stability was also investigated by circular dichroism
spectroscopy technique [10]. It was estimated that the N-terminal domain of
the complex melts at ∼66 °C, whereas the C-terminal domain melts at ∼44 °C,
indicating that the C-terminal region of the SNARE complex is less stable. From
these experimental results, it was proposed that the SNARE complex formation
proceeds in a zipper-like fashion from the N- to the C- terminus (although this
model has been challenged [15]), thus pulling the vesicle and the membrane
together to lead to vesicle-plasma membrane fusion and exocytosis [33, 25, 30].
1.2 The SNARE complex energy output and the fusion pore
During exocytosis, vesicles at the plasma membrane, dock, fuse and release neu-
rotransmitters through a fusion pore. As we have previously discussed, 50 to
70 residues (SNARE motif) of SNAP-25, syntaxin and synaptobrevin assemble
themselves into a complex [38] [Fig.1.2 A]. However, it was recently shown
that this helical bundle continues into the membrane through the interaction of
the synaptobrevin and syntaxin transmembrane domains [36] [Fig.1.2 C]. From
this observation, it was proposed that the transition from unstructured single
SNARE proteins to a zipped complex releases energy which is transferred to
the lipid membranes via the transmembrane domains (TMD) of synaptobrevin
and syntaxin [Fig.1.2 C, yellow]. But, is this energy sufficient to drive the fu-
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sion of the vesicle with the plasma membrane or to create a pore through which
molecules can be secreted?
1.2.1 The SNAREs: Minimum machinery for exocytosis?
Weber and colleagues initially reconstituted the basic fusion machinery in a li-
posome system [43], that is to say only the SNARE proteins and lipid mem-
branes were used. They observed that the liposomes exchanged their contents,
suggesting that the SNARE proteins were sufficient to induce liposome-liposome
fusion. However the kinetics of this fusion was extremely slow, taking hours
for completion, in comparison to millisecond kinetics of neurotransmitter secre-
tion observed in cells [1]. This inconsistency in the time scale of the reactions
between the liposomes and the cells data was attributed to the fact that in cells,
the calcium sensor protein synaptotagmin also catalyzes the merger of the mem-
branes [45, 11, 22]. Hence, when the liposome assay was reconstituted with the
addition of the full length synaptotagmin protein or only its calcium sensing
domain, C2AB, sped up the fusion reaction [35, 39, 22], thus leading to faster
pore formation.
1.2.2 The SNARE complex energy
Inherent to exocytosis is the apposition of the vesicular and the plasma lipid
bilayers. It was suggested that for the SNAREs to overcome the electrostatic re-
pulsion induced by the apposition of the charged phospholipid head groups of
the membranes, the SNAREs would need to provide a free energy of activation
of about 40 KT [18]. However, it has not been possible to determine with accu-
racy the energy release by the SNARE complex formation in vivo, accordingly
it has been a challenge figuring out whether the SNAREs alone can lower this
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activation energy for fast vesicle fusion. Nevertheless, Li and colleagues [19]
have rather elegantly attempted to provide an estimate of the energy stored by
the complex. Using a surface forces apparatus, they estimated 35 KT for the sta-
bilization energy of the complex. However in this study, 12 to 25 residues of the
C-terminal regions were unstructured and the TMDs of synaptobrevin and syn-
taxin were deleted, suggesting that the 35 KT may represent the energy stored
by 3/4 of the SNARE complex. Thus, this would suggest that the formation of
one SNARE complex alone would already provide enough energy to deform
the membranes for the creation of a pore [40]. However, these studies were
performed in vitro where synaptotagmin was omitted. Synaptotagmin along
with other accessory proteins bind the SNARE complex at various stages prior
to vesicle fusion [4, 5, 37], thus the transition to generate the fusion of a vesicle
is not simply the assembly of the individual SNARE complex components.
1.3 Genesis of the fusion pore
The creation of a fusion pore is a rate limiting step in exocytosis, and is therefore
the process that determines the speed at which vesicles fuse with the plasma
membrane [26]. Over the years, several experiments have been designed to as-
sess whether the SNARE complex formation affect the fusion pore properties.
The standard approach has been to mutate the SNARE proteins and to introduce
them into cells, then the fusion pore conductance and the flux of neurotrans-
mitters through the fusion pore is acquired from these cells and compared to
cells having non mutated proteins. The flux of catecholamine neurotransmitter
molecules through the fusion pore can be detected because they oxidize when
they make contact with a carbon fiber electrode held at a positive potential (am-
peromtry) [44, 13, 24]. In the amperometry technique, the electrode is pressed
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down onto the cell membrane. When a vesicle fuses with the plasma membrane
and releases its contents, neurotransmitters oxidize at the surface of the carbon
fiber where they give up two electrons per molecule [Fig.1.3 A]. This transfer of
electrons can be observed as transient spikes on the amperometry trace [Fig.1.3
B]. From the analysis of the amperometry spikes properties [Fig.1.3 B], the fu-
sion pore properties can be inferred. For example, the amperometry spikes are
often preceded by a pre-spike or “foot” [6] which provides a read out of the
initial neurotransmitter flux through the fusion pore [1].
To assess whether the SNARE complex conformational change is reflected
in the fusion pore properties, the foot signal that precedes the spikes was ana-
lyzed. When the complex was destabilized by mutating synaptobrevin-2 SNARE
motif in layer 8 of the C-terminal domain, the foot duration was reduced, indi-
cating the shortening of the fusion pore lifetime [41]. However, when the last
nine amino acids of the SNARE motif of SNAP-25 were deleted, the foot du-
ration increased [8] reflecting the elongation of the pore lifetime. Hence it is
evident that the stability of the SNARE complex is reflected in the properties of
the fusion pore.
Although there is a clear link between the SNARE proteins and the fusion
pore, it is not fully understood how the fusion pore is created, however sev-
eral models have been proposed to explain the genesis of the fusion pore. The
proteinaceous fusion pore model which postulates that the TMD of syntaxin
and probably synaptobrevin-2 line the fusion pore channel in the first few mil-
liseconds of its existence [14]. This model is drawn from neurotransmitter flux
analysis done by Han et al. [14], which showed that when some residues of the
TMD of syntaxin were replaced by a bulky tryptophan amino acid, the pre-spike
amperometric amplitude during exocytosis was reduced. This model also pos-
tulates that, the pore expands because the TMDs dissociate during the fusion
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Figure 1.3: (A) The oxidation of catecholamine releases two electrons. (B) Am-
perometric current trace recorded from a chromaffin cell. (C) Repre-
sentation of amperometry event parameters. (Modified figure from
Chapter V).
pore expansion [Fig 1.4 A] [16]. The caveat with this view is that the TMD of
synaptobrevin and syntaxin are composed of hydrophobic residues, hence it is
difficult to picture a pore formation with hydrophobic residues that allows for
the diffusion of hydrated cations [12].
To circumvent this problem, the proteolipidic fusion pore model was pro-
posed [Fig 1.4 B] [46]. In this model, the fusion pore lines up with lipids and
proteins, such that the hydrophilic lipid head groups would face the interior of
the pore, thus providing a means for the cation molecules to diffuse. Although,
the steps leading to such a fusion pore structure are unclear.
Unlike the previous models, a purely lipidic pore is an alternative model
that excludes the participation of the SNARE proteins. In this model, the two
membranes initially in apposition, create a stable link between the outer leaflets.
As the lipid membranes expand, the structure transits to a hemifusion state, and
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the formation of a fluidic connection between two membranes follows [Fig 1.4
C]. In SNAREs dependent exocytosis, this model has faced conceptual limita-
tion as reviewed in [46, 21].
In conclusion, mutating the SNARE proteins and using the amperometry
technique has offered an unprecedented means to link the SNARE complex and
the fusion pore. However, there is still not enough consistent data to discrimi-
nate between the different fusion pore models.
A B C
Figure 1.4: (A) The proteinous pore model proposes an initial pore composed
solely of proteins. (B) The proteolipidic model suggests that both
lipids and proteins constitute the fusion pore. (C) In the lipidic pore
model, the lipids form the pore (Figures modified from [2, 16]).
1.4 Current contribution
In this thesis, the role of the transmembrane domain of synaptobrevin in exocy-
tosis will be studied. This work was motivated by the fact that synaptobrevin
is essential for SNARE dependent exocytosis, and it is the only protein of the
SNARE complex which is linked to the vesicle. Although the function of its
SNARE motif has been determined, the role of its transmembrane domain has
only been speculative. It has been proposed for instance that the binding of the
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C-terminal domain of the SNARE motifs releases energy which is transfered to
the membranes by means of the transmembrane domains of synaptobrevin and
syntaxin [36] and, it has also been suggested that the transmembrane domain
of synaptobrevin lines the fusion pore [15]. However, there is no experimen-
tal evidence backing up these claims. Here, by mutating the transmembrane
domain of synaptobrevin and by using caged-calcium flash photolysis, amper-
ometry, TIRF microscopy, and fluorescence techniques, we attempt to elucidate
the function of synaptobrevin transmembrane domain. This thesis is divided
in chapters, where each chapter discuss different regions of the transmembrane
domain and its potential role.
Chapter II will give a brief overview of the caged-calcium flash photol-
ysis technique. Chapter III focuses on the C-terminal end of synaptobrevin-2
and its function for exocytosis. Chapter IV explores the effect of adding a GFP
tag at the N- or C-terminal end synaptobrevin on exocytosis in chromaffin cells.
Chapter V addresses the question as to whether the transmembrane domain of
synaptobrevin line the fusion pore. Chapter VI explores the topic of the trans-
membrane dimerization and will discuss its potential function in exocytosis.
Finally in the conclusion, all the results will be summarized and future work
will be discussed.
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CHAPTER 2
EXPERIMENTAL PROCEDURES
2.1 Abstract
The influx of calcium ions is needed to trigger the immediate fusion of vesi-
cles with the plasma membrane, thus the instantaneous release of neurotrans-
mitters. In recent years, the caged-calcium flash photolysis technique has been
developed. It provides the advantage that calcium molecules can rapidly and
homogeneously be released into the cell, while the fusion of vesicles with the
plasma membrane is monitored via the change of the cell membrane capaci-
tance.
2.2 Introduction
Calcium ions play an important role during exocytosis in neurons and in neu-
roendocrine cells. Physiologically, exocytosis in neurons and in chromaffin cells
is activated by action potentials. The action potential opens voltage-gated Ca2+
channels, Ca2+ ions flow into the cells elevating the free intracellular Ca2+ con-
centration and stimulating the fusion of secretory vesicles with the plasma mem-
brane. In whole-cell patch-clamp experiment, in voltage clamp mode, depolar-
izing pulses can be given to activate Ca2+ current and to stimulate exocytosis
[10, 9]. The disadvantage of this method is that the free intracellular Ca2+ con-
centration is not homogeneous throughout the cell. When the Ca2+ channels
open, the Ca2+ concentration near the channels and near the plasma membrane
tend to be higher than the Ca2+ concentration deeper in the cell. Thus, in re-
sponse to depolarization, a Ca2+ concentration gradient occurs inside the cell.
To overcome this limitation, the caged-calcium flash photolysis was developed
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[14, 8, 11, 15, 16, 13]. The main advantage of this technique is that, exocyto-
sis can be stimulated with a known calcium concentration that is homogeneous
throughout the cell, while the fusion of vesicles with the plasma membrane is
being monitored.
2.3 Whole-cell capacitance measurement
The whole-cell patch-clamp configuration provides a means to dialyze the in-
terior of the cell with a pipette solution, while also monitoring the entire cell’s
electrical properties. The whole-cell configuration is typically obtained by us-
ing a glass micro pipette with a diameter of 1-3 µm. The pipette tip is coated
with wax, and fire polished for smoothness as well as noise and stray capaci-
tance reduction. The pipette is used to make contact with the cell surface. Upon
touching the cell membrane, a small suction is applied such that part of the
membrane is sucked inside the micropipette tip forming an omega shape. For a
good seal, the resistance between the pipette and the cell membrane should be
on the order of GΩ. To have access to the interior of the cell, the patch is broken
with a brief suction pulse (whole-cell configuration).
The cell membrane is made-up of a lipid bilayer which separates two con-
ductive media of different potentials. Therefore, it can be modeled as a parallel
plate capacitor. Fig. 2.1 shows the minimal equivalent circuit of the whole-cell
patch clamp configuration. The elements of the equivalent circuits are Cm the
cell membrane capacitance, Gm = 1/Rm the conductance of the cell membrane
and Ra the access resistance. The smaller Ra the easier the pipette solution can
diffuse into the cell. To measure the electrical current that passes through a
cell membrane, an Ag|AgCl electrode connects the saline solution of the mi-
cropipette to a low noise amplifier, and another electrode is placed in the bath
20
solution and is connected to ground.
For capacitance measurement, a continuous sine wave of 70 mV peak to peak
amplitude and 800 Hz frequency, is added to a -70 mV DC holding membrane
potential, and is applied through the Ag|AgCl electrode, to charge or to dis-
charge the cell membrane. The resulting membrane current is fed into a LockIn
amplifier [7, 6] which distinguishes the real and the imaginary part of the cur-
rent based on 90° phase shift.
Figure 2.1: Equivalent circuit of a whole-cell patch-clamp configuration. Cm and
Gm represent the cell membrane capacitance and conductance. Erev
is the reversal potential, and Ra is the access resistance. Rs is the
seal resistance which is in the GΩ range and can be neglected. Cp
is the pipette capacitance which can be compensated by the Cfast
compensation circuit setting of the amplifier.
When the sinusoidal voltage V(t) is applied across the cell membrane, the re-
sulting current I is given by:
V(t) = V0 cos(ωt). (2.1)
I = VY(ω). (2.2)
Here, ω is the frequency and Y(ω) is the admittance of the equivalent circuit in
Fig. 2.1 [3].
Y(ω) =
1 + ω2RmRsC2m
Rt(1 + ω2R2sC2m)
+
jωR2mCm
Rt(1 + ω2R2sC2m)
(2.3)
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Rt and Rs are given by:
Rt = Rm + Ra (2.4)
Rs =
RmRa
Rm + Ra
(2.5)
The DC holding potential Vdc is added to the sinusoidal voltage stimulus, and it
is given by:
Vdc = IdcRt + Erev (2.6)
Where Idc is the DC holding current and Erev is the reversal potential.
From the equations 2.3 and 2.6, the equivalent circuit parameters are calculated
[3]:
Ra =
A +Gt
A2 + B2 − AGt (2.7)
Rm =
1
Gt
(A −Gt)2 + B2
A2 + B2 − AGt (2.8)
Cm =
1
ωcB
(A2 + B2 − AGt)2
(A −Gt) + B2 (2.9)
Where A and B are:
A =
1 + ω2RmRsC2m
Rt(1 + ω2R2sC2m)
(2.10)
B =
jωR2mCm
Rt(1 + ω2R2sC2m)
(2.11)
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2.4 Calcium Flash Photolysis
Once the access to the interior of the cell is gained at whole-cell patch-clamp
configuration, calcium ions bound to the photolabile o-nitrophenyl-EGTA (NP-
EGTA) mixed in solution with two calcium dyes Fura-4F and Mag-fura-2 is
loaded into the cell through a patch pipette. While Fura-4F has a high affin-
ity for calcium (Kd ∼ 0.145 µM), Mag-fura-2 has a low affinity (Kd ∼25 µM ) for
calcium. These two dyes are used in combination to assess calcium concentra-
tions ranging from ∼50 nM to ∼100 µM.
Calcium ions bound to the chelator NP-EGTA are inactive and unavail-
able for the cell to use [2, 5] [Fig. 2.2]. The chelator NP-EGTA is chosen because
its Kd for calcium is ∼80 nM, and upon the exposure of the complex NP-EGTA-
calcium to UV light (350 nm), the NP-EGTA breaks down into products with
reduced affinity for calcium (Kd ∼1 mM). When a cell loaded with NP-EGTA-
calcium complex is irradiated with UV light pulses, the calcium is liberated and
its concentration increases throughout the cell, including at its site of action.
This provides the advantage that the time of activation of exocytosis is fast and
the time course of vesicle fusion with the plasma membrane can be resolved
on a millisecond time scale. However, NP-EGTA should be used at concentra-
tion where it is saturated with calcium to avoid that the newly released calcium
concentration bind back to the chelator.
2.5 Equipments
Whole-cell capacitance measurements were performed with an EPC 9 or EPC
10 amplifier (HEKA) using the internal LockIn detection software. The applied
stimulus is a sine wave of 70 mV peak to peak amplitude added to a -70 mV
holding membrane potential. The xenon flash lamp is one of the main com-
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Figure 2.2: Calcium molecule bounds to NP-EGTA (Invitrogen).
ponents of the caged-calcium flash set-up [Fig.2.3], it produces a brief pulse of
about 1 ms in the range of 250 to 1500 nm. The UV range is used to uncage
the calcium ion from the NP-EGTA-calcium complex. A two-port condenser is
mounted to an inverted light microscope in order to couple the lights from the
flash lamp and the monochromator. The emitted photons are captured using a
photomultiplier, and a computer is used to store and process data.
Microscope: The Zeiss Axiovert 135 (Zeiss) inverted light microscope with a 40X
NA 0.75 (Zeiss) objective is equipped with a photomultiplier and a camera. The
photomultiplier is used to collect fluorescence emission from the cell and the
camera is used to visually place the cells in the field of illumination.
A two-port condenser, type photometry (TILL Photonics GmbH, Germany) is at-
tached to the microscope to merge lights from the flash lamp and the fluorescent
excitation into the light path of the microscope. This condenser is equipped with
a quartz beam splitter that transmits 92% of the flash lamp light and 8% of the
fluorescence excitation light. The two-port condenser is also used to adjust the
field stop and to restrict the illuminated area around the cell diameter.
Fluorescence excitation: The monochromator (Polychrome II, TILL Photonics GmbH,
Germany) is connected to the microscope using a light guide which is inserted
into the monochromator port of the two-port condenser. The UV light from
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Figure 2.3: The EPC 9 amplifier is connected to the computer and is controlled
by the patchmaster soltware. The voltage stimulus is applied to the
cell through a pipette electrode. The monochromator and the flash
lamp is controlled by the computer. 8% light from the monochroma-
tor and 92% light from the flash are coupled into the light path of
the microscope via a beam splitter. The microscope is equiped with
a dicroid mirror (415 - 570 nm) and an emission filter (510 nm/84 nm
). The emission light from the fluorescent dyes is collected using a
dectector (photomultiplier) which is connected to the amplifier.
the monochromator is used to excite the calcium indicator dyes by alternating
wavelengths between 350 nm and 380 nm at 20 s interval (see calcium measure-
ment). For accurate measurements, the monochromator is re-calibrated every
time the lamp is exchanged. This is done following the manufacture instruc-
tion, and while wearing a protective UV eye glasses.
A xenon flash lamp (Gert Rapp Optoelektronik, Hamburg, Germany) is connected
to the second input on the two-port condenser. The lamp produced a brief pulse
of about 1 ms in the UV range 300-400 nm, in order to uncage the calcium from
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the NP-EGTA. The intensity of the flash lamp is optimized for the uncaging of
calcium concentrations ranging from ∼25-30 µM.The light intensity of the flash
lamp can be controlled by placing a neutral density filter in the illumination
light path of the flash lamp. Nevertheless, the light intensity should be suffi-
ciently high to uncage Ca2+ since the flash intensity determine the size of [Ca2+]i.
While using the UV flash, caution must be taken to limit the production of free
radicals resulting from the photodamage of the NP-EGTA, because they could
interfere with physiological function of the cell.
Fluorescence detection: A photomultiplier tube is used for the detection of pho-
tons emitted from the cell as a result of the excitation of the calcium dyes.
Patch-clamp amplifier: The EPC 9 (Heka Elektronik, Lambrecht, Germany) am-
plifier is used to acquire whole-cell patch membrane current. The monochroma-
tor and the flash lamp are connected with a BNC cable to the D/A outputs of the
EPC 9. The EPC 9 head stage, is connected to the glass pipette via a silver wire
electrode. EPC 9 has the advantage that it has an integrated ITC-16 AD/DA
which can be controlled by the PatchMaster (or pulse) software. The ITC-16 in
the EPC 9 also acquires pipette current, performs Cm determination and records
fluorescence intensity.
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Amperometry amplifier (optional): An EPC 7 (HEKA) is used as the sec-
ond amplifier to acquire the amperometric current. The amplifier’s built in
3 kHz filter is used during the acquisition of the data. The head stage of the
amplifier is connected to a carbon fiber electrode and shares the same ground
with the EPC 9 head stage. A 7 volt constant voltage providing a holding poten-
tial of +700 mV is connected to the stimulus input of the ECP 7. A carbon fiber
held at 700 mV can oxidize the catecholamine molecules released by chromaffin
cells.
Softwares: PatchMaster (Heka Elektronik, Lambrecht, Germany) is a LockIn
software used to control the EPC 9 or EPC 10 amplifier. The PatchMaster soft-
ware is configured to continuously acquire two physical traces, the current trace
of the cell and the emission intensity of the fluorescent dyes. The LockIn mode
is set to ”Sine+DC” and is used to extract the capacitance and the conductance
values.
IgorPro software (WaveMetrics, Inc., Oregon) is used for offline data analysis.
2.6 Calibration
To calibrate the [Ca2+] measurement , multiple solutions with various concen-
trations of calcium from basal to saturation is used (Table 2.6). The calibra-
tion is achieved by infusing into a cell, solutions containing a known free cal-
cium concentration buffered with 1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-
tetraacetate (BAPTA, Kd ∼ 150nM) at low calcium concentration and 1,3-di-
aminopropane-2-ol-N, N’-tetraacetate (DPTA ∼81 µM) at high calcium concen-
tration. In addition to calcium and buffers, the solutions also contained two
fluorescent dyes Fura-4F and Mag-fura-2. Upon binding the calcium, the dyes
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Figure 2.4: Fura-2 calcium binding spectrum (Invitrogen).
exhibit an absorption peak shift from 330 nm to 360 nm [Fig. 2.4] (Invitrogen),
with little shift on the emission at 510 nm. This characteristic enables the appli-
cation of a ratiometric analysis, which is done by alternating excitation of the
dyes at 350 nm and 380 nm respectively while collecting the fluorescence emis-
sion at 510 nm. The ratiometric analysis is preferred to the absolute fluorescence
analysis, because it eliminates artifacts from photobleaching, the slow diffusion
of the solution in cells and problems due to the optical path length and the vari-
ation of illumination intensity.
A stock of the buffer solution containing 100 mM Cs-glutamate and 32 mM
Hepes, titrated with CsOH to pH 7.2 was prepared separately. The buffer was
added to individual solutions in Table 2.6 until the total osmolarity of the so-
lution reached ∼ 290 mOsM. To determine the free calcium concentration in so-
lutions a custom-written IgorPro procedure was used, taking into account the
calcium binding affinity for DPTA or BAPTA, for fluorescent dyes, ATP and
nitrophenyl-EGTA. The computer programs MaxChelator which is freely avail-
able can also be used for the same purpose.
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Table 2.1: The calibration solutions are supplemented with ascorbic acid be-
cause it protects the fura dyes against photodamage caused by UV
light. Therefore, unlike previously described calibration procedure
[15], the postflash calibration is omitted [4].
Solution 1 2 3 4 5 6 7 8 9
Mg-ATP(mM) 2 2 2 2 2 2 2 2 2
Na-GTP(mM) 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Fura-4F (mM) 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4
Mag-fura-2(mM) 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4
Bapta (mM) 20 8 4.5 0.9 0.4 0 0
Ca-Bapta(mM) 12 15.5 19.1 0.4 0 0
Dpta (mM) 0 0 0 38.1 34.5 30.5 22.5 0
Ca-DPTA (mM) 0 0 0 1.9 5.5 9.5 17.5 0
ascorbic acid (mM) 1 1 1 1 1 1 1 1 1
CaCl2 (mM) 12.5
CaCl f ree (µM) 0 0.331 0.741 3.356 3.913 11.57 23.736 72.769 12.5
2.7 Ratiometric measurements
2.7.1 Cell preparation
The chromaffin cells are isolated by enzymatic reaction from the adrenal gland
as previously described [1, 11]. They are then plated onto coverslips and cul-
tured for 2 to 4 days. During the experiment, the cells bathed in solution com-
posed of (in mM): 145 NaCl, 1 MgCl2, 2.8 KCl, 2 CaCl2 and 10 HEPES. The pH
and osmolarity are adjusted to 7.2 with NaOH and to 310 mOSM with D-glucose
whenever necessary.
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2.7.2 Calibration procedure
The fluorescence ratio signal is calibrated by infusing the calibration solutions
into chromaffin cells at whole-cell patch clamp configuration through the patch
pipette [15]. A cell loaded with the calibration solution is illuminated by alter-
nating the monochromator light between 350 nm and 380 nm every 20 ms. The
photomultiplier is used to collect photons emitted at 510 nm/84 nm by the fura
dyes, and the ratiometric values (380/350) are calculated and plotted versus the
calcium concentrations [Fig. 2.5].
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Figure 2.5: Each data point consisted of at least three measurements. The points
are best fitted (solid line) with R = R0−R1 [Ca2+]K1+[Ca2+] +R2
[Ca2+]
K2+[Ca2+]
, which
takes into account the binding of calcium ions to the two calcium
dyes. The fit is used to convert the ratio R at 380/350 nm of the fluo-
rescent signal into the [Ca2+]i [15].
For given fluorescence ratio values, the free calcium concentration is cal-
culated. For one fluorescence dye, the free calcium concentration is given by:
[Ca2+] = Ke f f
(R − Rmin)
Rmax − R (2.12)
Where Rmin is the fluorescence ratio obtained for the lowest free calcium, and
Rmax is the ratio obtained for the highest free calcium in solution. Rmin, Rmax and
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Ke f f parameters are obtained experimentally. Rearranging equation 2.12 as fol-
lows:
Rmax − R = Ke f f[Ca2+] (R − Rmin) (2.13)
Rmax − Rmin Ke f f[Ca2+] = R
Ke f f + [Ca2+]
[Ca2+]
(2.14)
R = Rmin
Ke f f
Ke f f + [Ca2+]
+ Rmax
[Ca2+]
Ke f f + [Ca2+]
(2.15)
R = Rmin − (Rmin − Rmax) [Ca
2+]
Ke f f + [Ca2+]
(2.16)
R = Rmin − (Rmin − Rmax) [Ca
2+]
Ke f f + [Ca2+]
(2.17)
R = R0 − R1 [Ca
2+]
K1 + [Ca2+]
(2.18)
Where R0 = Rmin and R1 = Rmin − Rmax and K1 = Ke f f . This provides a convenient
parametrization of the fluorescence ratio R as a function of the free [Ca2+]i.
When two fluorescence dyes are combined, this equation 2.18 becomes:
R = R0 − R1 [Ca
2+]
K1 + [Ca2+]
− R2 [Ca
2+]
K2 + [Ca2+]
(2.19)
where R0 reflects the ratio R at [Ca2+]i = 0 and R0−R1−R2 is the ratio at the highest
value of [Ca2+]i. Fitting the parameters R0, R1, R2, K1, and K2 of equation 2.19
to the calibration data points as shown in Fig. 2.5 provides the calibration to
determine [Ca2+]i from the measured fluorescence ratio R.
2.8 Experimental procedures
To study exocytosis in chromaffin cells, cells are infused at whole-cell configura-
tion with solution containing (in mM): 0.4 fura-4F, 0.4 Mag-fura-2 (Invitrogen),
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5 Nitrophenyl-EGTA (NP-EGTA, Synaptic Systems), 100 Cs-glutamate, 0.3 Na-
GTP, 2 Mg-ATP, 4 CaCl2, 1 ascorbic acid and 32 HEPES, pH 7.2. Intracellular
calcium measurements are performed by alternating the fura-4F/Mag-fura-2
excitation wavelength between 350 nm and 380 nm [Fig.2.6] [15]. Photolysis
of NP-EGTA is achieved by a UV flash [Fig.2.6, arrow], calcium molecules are
freed from the calcium chelator and this results in an increase of calcium inside
the cell. The increase of [Ca2+] induced the increase of the cell membrane ca-
pacitance [Fig.2.6, brown line], indicating the fusion of vesicles with the plasma
membrane.
The analysis of the capacitance trace [Fig.2.7] can yield information about
the kinetics of the exocytotic process. The steep increase or the burst phase of
the capacitance trace reflects the fusion of vesicles at the surface of the plasma
membrane ready to fuse prior to the elevation of calcium. This phase can be fit-
ted with the sum of two exponentials functions and has been associated with the
fusion of vesicles of the readily releasable pool (RRP) and the slowly releasable
pool (SRP) [15]. The sustained phase, which is the region of the capacitance trace
which increases with a time constant of seconds, reflects the fusion of vesicles
which slowly refill the ready releasable pool. These vesicles fuse immediately
as long as the calcium concentration in the cell remained high. For a detailed
review of the RRP and the SRP see [12].
2.9 Conclusion
Caged-calcium Flash Photolysis technique has become a very useful tool to
study the kinetic of fusion in exocytosis. In all subsequent chapters this was
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the main approach used to study the role of the transmembrane domain of the
SNARE protein synaptobrevin-2 during vesicle fusion.
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CHAPTER 3
ROLE OF THE SYNAPTOBREVIN C-TERMINUS IN FUSION PORE
FORMATION
3.1 Abstract
Neurotransmitter release is mediated by the SNARE proteins synaptobrevin II
(SybII, also known as VAMP2), syntaxin and SNAP-25 generating a force trans-
fer to the membranes and inducing fusion pore formation. However, the molec-
ular mechanism by which this force leads to opening of a fusion pore remains
elusive. Here we show that the ability of SybII to support exocytosis is inhibited
by addition of one or two residues to the SybII C-terminus depending on their
energy of transfer from water to the membrane interface, following a Boltzmann
distribution. These results suggest that following stimulation, the SNARE com-
plex pulls the C-terminus of SybII deeper into the vesicle membrane, with this
movement disrupting the vesicular membrane continuity and leading to fusion
pore formation. In contrast to current models, the experiments suggest that fu-
sion pore formation begins with molecular rearrangements at the intravesicular
membrane leaflet and not between the apposed cytoplasmic leaflets.
Running Title:
Movement of synaptobrevin C-terminus induces fusion
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3.2 Introduction
The SNARE proteins [21] mediate release of stored secretory products by exo-
cytosis. In neurosecretion, the t-SNAREs syntaxin and SNAP-25 in the plasma
membrane bind the v-SNARE synaptobrevin II (SybII, also known as VAMP2),
which is anchored to the vesicle membrane by a single transmembrane do-
main (TMD) . Upon stimulation, the SNARE complex is thought to zip up more
tightly proceeding in a vectorial manner from the N- to the C-terminus, towards
the TMD of sybII and syntaxin [5, 18, 23, 29], thereby transferring a force to the
membranes [16]. However, the molecular mechanism by which this force leads
to opening of the fusion pore has not been determined [19].
Several models have been proposed to explain the mechanism of fusion
pore formation. In the lipid-stalk-hemifusion hypothesis, the outer and the in-
ner leaflets of the two membranes merge via formation of a hemifusion interme-
diate in response to forces exerted by proteins surrounding the fusion site [37].
In an alternative proteinaceous fusion pore model, the fusion pore is lined by
the TMD of syntaxin [12] and possibly synaptobrevin [12]. However, it is not
immediately evident how the hydrophobic transmembrane domains can line
an aqueous fusion pore that allows for ion permeation by electrodiffusion [10].
When the C-terminal SNARE domain interactions are reduced by mutating or
deleting the C-terminus of SNAP-25, or when flexible linkers are introduced be-
tween the sybII TMD and its SNARE domain, the rate of exocytosis is reduced
[6, 7, 13, 30, 35] and the flux of transmitter through the early fusion pore is de-
creased [9, 13], consistent with a structural change in the fusion pore. In an
attempt to interpret these findings, a proteolipidic fusion pore model has been
proposed, in which the fusion pore formed by a molecular complex of both
lipids and SNARE proteins [9]. However, even this model does not explain
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the molecular mechanism by which the N-to C-terminal zipping of the SNARE
complex leads to the formation of a fusion pore, a step that must somehow dis-
rupt membrane continuity.
3.3 Results
3.3.1 Addition of polar amino acids to the SybII C-terminus in-
hibits fusion
To determine a possible role of the SybII TMD in fusion pore formation, SybII
constructs were generated in which two charged residues (lysine or glutamate)
were added to the C-terminus of SybII. To determine whether these C-terminal
mutants localize to secretory vesicles, synaptobrevin constructs were generated
that carried a GFP tag at their N-terminus. Wild-type GFP-SybII, GFP-SybII-KK,
and GFP-sybII-EE were expressed in mouse chromaffin cells and imaged by To-
tal Internal Reflection Fluorescence (TIRF) microscopy [Fig. 3.3.1A-C]. While
a considerable fraction of the SybII constructs is localized in the plasma mem-
brane as expected [32] and generates diffuse fluorescence, punctate fluores-
cence is clearly visible, indicating vesicular localization.
To determine if the vesicles carrying these constructs are fusion competent,
simultaneous TIRF microscopy and recording of catecholamine release from the
cell membrane in contact with the coverslip was performed using microfabri-
cated electrochemical detector arrays [11]. This method allows determination
of time and location of a fusion event by amperometric recordings with multi-
ple electrodes. It can then be determined if a fusion event is accompanied by
loss of a fluorescent granule. Amperometrically detected exocytotic events as-
sociated with disappearance of GFP-SybII fluorescence puncta were observed
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when the construct carried the unmodified SybII TMD [Fig. 3.3.1 A], indicating
that vesicles carrying GFP-sybII are fusion competent. In contrast, no such cor-
related events were observed for GFP-SybII-KK or GFP-SybII-EE fluorescence
puncta, indicating that the modification of the SybII C-terminus by addition of
these charged residues renders the vesicles fusion incompetent. However, those
cells did show quantal release events [Fig.3.3.1 B,C], presumably from vesicles
carrying mainly wild-type sybII with undetectable amounts of GFP-SybII-KK
or GFP-SybII-EE. These wild-type SybII granules were presumably generated
in the cell before the GFP construct was expressed.
To quantify the inhibition of exocytosis, chromaffin cells overexpressing
a sybII construct and identified by GFP fluorescence were stimulated by flash
photolysis of caged-calcium (NP-EGTA) [28], and exocytosis was monitored
by whole-cell capacitance measurements [14] while the associated transmitter
release was monitored by carbon fiber amperometry [33]. The exocytotic re-
sponse in cells overexpressing wt sybII consists of an exocytotic burst on the
millisecond time scale followed by a sustained phase on a time scale of seconds
[Fig. 3.3.1 D, black trace], which is indistinguishable from the response of non-
infected wild-type chromaffin cells (data not shown). When sybII-EE was ex-
pressed in wild-type chromaffin cells and exocytosis stimulated by photorelease
of caged calcium [Fig. 3.3.1 D, red trace], the burst amplitude and the sustained
phase were moderately reduced by 35% and 27%, respectively. This inhibition
provides further evidence that the mutant protein is correctly sorted to secretory
vesicles. The exocytotic burst kinetics was unchanged [Fig. 3.3.1E], consistent
with the conclusion that the population of vesicles that carry the sybII-EE con-
struct is unable to undergo exocytosis
To eliminate the contribution of wild-type SybII to the exocytotic resp-
sonse, experiments were performed using double knock-out (DKO) embryonic
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Figure 3.1: Vesicular localization of GFP-SybII, GFP-SybII-KK and GFP-SybII-EE
in mouse chromaffin cells. (A-C) Simultaneous ECD array amper-
ometry and TIRF microscopy imaging of wild-type cells expressing
GFP-SybII (A), GFP-SybII-KK (B) and GFP-SybII-EE (C). Scale bars
are 2 µm. Colors of amperometric traces (top panels) correspond to
the respective electrodes as indicated by colored dots in images be-
low. Frame acquisition timing of the image sequences is indicated
below the amperometric traces. In a GFP-SybII cell (A), two amper-
ometric events detected by multiple electrodes of the ECD array are
associated with loss of fluorescence puncta between frames 539-540
(red arrow) and 541-542 (blue arrow). The area in the yellow rectan-
gle is enlarged in the bottom panel. In a GFP-SybII-KK cell (B) and
a GFP-SybII-EE cell (C) amperometric events (top) are not associated
with loss of fluorescence puncta in TIRF images (bottom). (D) SybII-
EE expression in wild-type cells (n=16) reduces the exocytotic burst
amplitude by 35% (P<0.05) and the amplitude of the sustained phase
by 27% (p=0.07) compared to cells overexpressing wild-type SybII.
(e) Normalization of capacitance increase 0.6 s after the flash shows
that SybII-EE overexpression in wild-type cells does not change the
exocytotic burst kinetics.
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mouse chromaffin cells deficient in SybII and cellubrevin [3, 20, 36]. As in wild-
type chromaffin cells, vesicular localization of GFP-SybII, GFP-SybII-KK, and
GFP-SybII-EE is clearly evident in DKO embryonic chromaffin cells by TIRF
microscopy [Fig. 3.2]. In comparison with [Fig. 3.3.1 A-C], the vesicular local-
ization is seen even more clearly. We attribute this difference to a lower back-
ground of SybII in the plasma membrane and/or a lower density of granules
in embryonic cells that reduces overlap of fluorescence from adjacent granules
and blurred by the microscope point spread function.
10
0
50
0
350300250200150100500 A B C
Figure 3.2: Expression of GFP-SybII (A), GFP-SybII-EE (B) and GFP-SybII-KK
(C) in SybII/ceb DKO embryonic mouse chromaffin cells reveals
vesicular localization of all three constructs in the absence of wild-
type SybII.
To assess what properties determine the ability of the C-terminally mod-
ified constructs to support vesicle fusion, several constructs were generated
where one or two polar or non-polar residues were added at the C-terminus
of the protein [Fig. 3.3A]. These constructs were expressed in DKO embryonic
mouse chromaffin cells and exocytosis was stimulated by flash photolysis of
NP-EGTA. The amplitude and kinetics of exocytosis were quantified by capaci-
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tance measurements and compared to those recorded in cells in which wild-type
SybII was expressed using the same viral expression method.
As previously reported [3, 13], DKO chromaffin cells did not support exo-
cytosis [Fig. 3.3 B blue traces], while viral expression of wild-type SybII restored
a biphasic increase in capacitance [Fig. 3.3 B, black traces], indistinguishable
from that observed in embryonic chromaffin cells from normal wild-type mice
(data not shown). In contrast, when SybII-KK was expressed [Fig. 3.3 B, red
traces], the response was indistinguishable from DKO [Fig. 3.3 C,D], indicating
that this mutant protein failed to support vesicle fusion. Even addition of only
a single lysine [SybII-K] reduced the exocytotic burst as well as the sustained
phase by ∼80% and similar reductions were observed with addition of other
charged residues (-E, -EE, -HH) [Fig. 3.3 C,D].
3.3.2 Inhibition of fusion is related to amino acid polarity
To assess whether the inhibition of exocytosis is specifically due to the pres-
ence of charged residues at the C-terminius of SybII we tested the uncharged
amino acids glutamine (SybII-QQ), glycine [SybII-GG] and valine [SybII-VV]
[Fig.3.4]. While SybII-QQ expressing cells showed again only a very small exo-
cytotic response, the response of cells expressing SybII-GG was not significantly
different from control cells expressing wild-type SybII. The response of cells ex-
pressing SybII-VV was intermediate, showing a moderate reduction of 26% for
the burst and of 40% (p=0.07) for the sustained phase [Fig. 3.4B]. When the re-
sponses were normalized [Fig.3.4C] the exocytotic burst shows slower kinetics
for SybII-VV and more so for SybII-QQ. The delay between the flash-induced
calcium release and the onset of the exocytotic burst also increased from 4.3 ms
for wild-type SybII to 6.7, 8.5 and 19.6 ms for sybII -GG, -VV and -QQ, respec-
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Figure 3.3: (A) SybII C-terminal mutations. X indicates added residues: single
lysine (K) or glutamic acid (E), or double lysine (KK), glutamic acid
(EE), glutamine (QQ), histidine (HH), valine (VV), or glycine (GG).
(B) Exocytosis was stimulated with intracellular release of caged-
calcium (top panel) using UV light at t = 0.5 s and monitored by
patch clamp capacitance measurement (middle panel) and carbon
fiber amperometry (lower panel). Exocytosis is virtually absent in
DKO cells (blue traces) but is rescued by viral expression of wild-
type sybII (black traces). Exocytosis is not rescued by expression of
SybII-KK (red traces). Traces are averages from 8 to 17 cells. The
exocytotic burst amplitude (C) was taken as the capacitance increase
at 0.5 s after stimulation and the amplitude of the sustained phase
(D) as the capacitance increase over the next 5 s. SybII-KK (n=8),
SybII-K (n=17), SybII-EE (n=12), SybII-E(n=17), and SybII-HH(n=11).
(*P<0.05, **P<0.01, ***P<0.001 student t-test).
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tively [Fig. 3.4D]. The kinetics of exocytosis is thus slowed down in parallel
with the reduction in exocytosis amplitude.
3.4 Discusion
Release of neurotransmitters from synaptic vesicles as well as exocytosis of
chromaffin granules is mediated by the neuronal SNAREs SybII, syntaxin-1 and
SNAP-25. The t-SNARE syntaxin and the v-SNARE synaptobrevin are anchored
by a single TMD to the plasma membrane and the vesicle membrane, respec-
tively. The SNARE domains of these proteins can form a four-stranded helical
bundle as revealed by the crystal structure [25]. It has been suggested that SybII
of vesicles in the readily releasable pool is bound tightly to the t-SNAREs only
in the N-terminal part of the SNARE complex, zipping up fully only after stim-
ulation [5, 18, 23]. Complexin interacts with the C-terminal part of the SNARE
complex and thereby activates and clamps SNARE complexes such that Ca2+
can trigger Synaptotagmin to reverse the clamping function [16]. In the zipper
model, this will allow N- to C-terminal zipping, which results in a force transfer
to the membranes. But how does the force, which is exerted by this machinery,
lead to fusion pore formation?
We have shown here that addition of polar residues to the intravesicular
C-terminus of the SybII TMD inhibits fusion dramatically. This is an unexpected
observation, because SybII has been modified by even adding a GFP variant to
its C-terminus in the synapto-pHluorin construct [17] that is widely used to
investigate exocytosis and recycling of secretory vesicles. However, in synapto-
pHluorin a flexible linker with the sequence SGGSGGTGG was inserted be-
tween the SybII C-terminus and GFP. This linker is rich in glycine residues,
which did not interfere with SybII function (see Fig. 3.4, SybII-GG construct). It
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Figure 3.4: Polarity of C-terminal additions determines fusion competence. (a)
Average biphasic capacitance responses (middle trace) and associ-
ated catecholamine secretion (Lower panel) after photorelease of
caged Ca2+ (upper trace). Wild-type SybII (black, n=14), SybII-GG
(green, n=20), SybII-VV (brown, n=17), SybII-QQ (red, n=12) and
DKO (blue, n=20). (B) The amplitudes of the exocytotic burst and
of the sustained phase are reduced in parallel. (C) Normalization of
the capacitance amplitude at 0.7 s after the flash reveals slower kinet-
ics of exocytosis associated with reduced amplitude. (D) SybII-GG
and SybII-VV show increase in delay between flash and onset of exo-
cytosis. Smooth curves (left panel) show the initial parts of multiex-
ponential fits. Statistical analysis of delays (right panel) determined
by backextrapolation of multiexponential fits to individual responses
indicate that only the increase in SybII-QQ is significant. (*P<0.05,
**P<0.01 ***P<0.001 student’s t-test).
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thus appears that the nature of the residues near the intravesicular membrane-
water interface is of particular importance. The inhibition of fusion by addition
of polar residues suggests that fusion may be the consequence of a movement
of the C-terminus towards the hydrophobic core of the vesicle membrane. We
therefore compared the ability of the different SybII mutants to support exocy-
tosis to the free energies of transfer from water to the membrane-water interface
(∆Gwi f ) [31] for the residues added to the SybII C-terminus.
3.4.1 Inhibition of fusion depends on free energy of transfer
from water to the membrane-water interface
The transfer energies for the residues used here are given in Table 3.5.5. It has
been shown that the transfer energies for multiple residues are additive [34] and
we therefore assigned the value given in [31] for addition of a single residue and
twice that value for the addition of two residues. For glutamate and histidine
∆Gwi f is uncertain because it strongly depends on the protonation state of these
residues near the interfacial layer inside the acidic vesicle (see corresponding
section in Experimental Methods). The relation between ∆Gwi f for the added
residues and the amplitude of the exocytotic burst is shown in Fig. 5a. The
ability to support exocytosis decreases with increased ∆Gwi f . The dashed line
shows a fit of the function
∆Cburst = A · exp(∆Gwi f /E) + B,
yielding E = 0.66±0.16kcal/mol, consistent with a Boltzmann distribution [Fig.
3.5a, solid line] with E ∼ RT = 0.59kcal/mol for T=295 K. This result indicates
that the ability of the different mutants to support the exocytotic burst correlates
directly with the energy required to move the added residues from water into
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the interfacial layer.
3.4.2 The mechanism of fusion pore formation
While it is possible that added residues with high ∆Gwi f may change the posi-
tion the SybII TMD in the membrane and could thereby compromise the abil-
ity of SybII to participate in SNARE complex formation, it appears more likely
that fusion pore formation is initiated by pulling the SybII TMD into the vesicle
membrane, a movement that would translocate the C-terminally added residues
from the water phase to the membrane interface. Such a mechanism is also sup-
ported by the finding that a reduction in exocytosis amplitude is accompanied
by slowing of the kinetics [Fig. 3.4C,D], as expected for an increased height of
the energy barrier. Consistent with this model is also the finding that introduc-
tion of flexible linkers between the SybII SNARE domain and its TMD reduces
exocytosis in parallel with the length of the linkers [13].
Properties of the early fusion pore are reflected in amperometric foot sig-
nals. The SybII-VV construct was chosen for comparison with wild-type SybII
because it produces limited inhibition allowing better statistical analysis of am-
perometric foot signals [Table 3.4.2]. Embryonic DKO chromaffin cells express-
ing SybII-VV showed no change in foot current amplitude indicating that this
mutation does not affect the fusion pore structure. However, a small but sig-
nificant decrease in foot duration by about 20% (data not shown) was observed
for SybII-VV compared to wild-type sybII, which points to small change in the
energetics of fusion pore expansion. This mutant has a higher energy in the
interfacial layer (∼0.14 kcal/mol for 2 valines) and it is thus expected to con-
tribute some additional distortion of the vesicle membrane, thereby lowering
the activation energy for fusion pore expansion. A reduction in fusion pore life-
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Figure 3.5: (a) Dependence of exocytotic burst amplitude on energy of transfer
from water to the membrane-water interface (∆Gwi f ) for the residues
added to the SybII C-terminus. The single exponential fit of the
function ∆Cburst = A · exp(−∆Gwi f /E) + B yielded the fit parameters
A = 88±6 fF, B = 4± 6 fF, and E = 0.66± 0.16kcal/mol. The solid lines
indicate a theoretical Boltzmann distribution fitting only amplitude A
and baseline B of the exponential. The data points for SybII-HH and
SybII-EE were excluded from the fit (see text). (b-e) Schematic model
of fusion pore opening, for clarity only synaptobrevin and syntaxin
are shown. Pre-fusion arrangement of N-terminally zipped SNARE
complex (b). C-terminal zipping pulls C-termini of SybII and possi-
bly syntaxin deeper into the membrane disrupting membrane conti-
nuity (c) leading to fusion pore formation (d) and pairing up of the
SybII and syntaxin TMD (e).
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time is thus also consistent with the model proposed here. Interestingly, using a
simple activation energy model, the ∼20% reduction in fusion pore lifetime cor-
responds to a change in activation energy by ∼0.13 kcal/mol, which equals the
transfer energy from water to the membrane interface of the two valine residues.
Table 3.1: SybII-VV single amperometry spikes. *P<0.05
T f oot > 2ms
Imax[pA] T1/2 [ms] Q[pC] I f oot[pA] T f oot [ms] Q f oot [pC] I f oot [pA] T f oot [ms] Q f oot [pC]
SybII (n=19) 54.65±5.75 3.42± 0.36 0.34± 0.03 3.61± 0.34 3.73± 0.30 0.01± 0.002 5.11± 0.41 6.85± 0.56 0.038± 0.004
SybII-VV (n=24) 53.37±6.17 2.88±0.27 0.27±0.02 3.53±0.30 3.17±0.50 0.01±0.01 5.78±0.49 5.27±0.46* 0.034±0.004
The C-terminus of the wild-type SybII TMD is located in the interfacial
layer of the vesicle membrane [4] [Fig. 3.5b]. The aromatic residues Y113 and
F114 with their propensity for interfacial localization [31](are suitably posi-
tioned and are conserved in vertebrate SybII. Ceb, which also supports chro-
maffin granule exocytosis, has a tryptophan and a non-aromatic residue in the
corresponding position, which yields a very similar energy minimum for in-
terfacial localization. When the TMD is pulled deeper into the membrane, the
polar residues S115 and T116 may be pulled into the interfacial or hydropho-
bic layers [Fig.3.5c]. In some species (human, horse, bovine) T116 is substi-
tuted by S116 but Thr and Ser have identical ∆Gwi f . In ceb, there are also one
or more polar residues at the C-terminus conserving the essential properties.
As a consequence of this movement of the SybII C-terminus into the hydropho-
bic membrane domain, the stability of the vesicle membrane should be signifi-
cantly reduced followed by structural rearrangements leading to disruption of
membrane continuity and formation of a proteolipid fusion pore [Fig.3.5 d,e].
Consistent with this model is the recently reported X-ray structure of the neu-
ronal SNARE complex, consisting of syntaxin 1A, SNAP-25 and SybII, includ-
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ing the carboxy-terminal linkers and transmembrane regions [24]. In this post-
fusion structure [8], the C-termini of syntaxin and SybII appear to be pulled to-
wards the hydrophobic core of the membrane. In the zipper model of SNARE-
mediated fusion, the movement of the SybII C-terminus as a prerequisite for
fusion pore formation is expected to occur as a consequence of N- to C-terminal
zipping of the SNARE domains. A movement of the SybII C-terminus is, how-
ever, also consistent with the recently proposed scissors mechanism involving
a transition of the SybII TMD from a tilted conformation to one parallel to the
membrane normal [26].
The possibility of a proteolipid fusion pore was originally proposed by
[37] but the identity and function of the proteins participating in such a mech-
anism were unknown. In the model proposed here, the genesis of the pore
formation starts at the inner leaflet of the vesicle membrane and is induced by
movement of the C-terminal end of SybII. This movement is activated in re-
sponse to calcium stimulation via synaptotagmin, which may in addition aid
fusion pore formation by inducing membrane curvature [15]. It is possible that
the TMD of syntaxin plays a complementary role in disrupting the continuity of
the plasma membrane as depicted in Fig.3.5c of the model. However, we have
not performed experiments with corresponding syntaxin mutants to support or
discard such a role. The energy of C-terminal zipping of the SNARE complex
appears to be remarkably balanced with respect to overcoming the energy bar-
rier for fusion. It is just sufficient for the required SybII TMD movement as the
additional energy of a few kBT required for translocation of the added residues
significantly inhibits fusion competence.
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3.5 Experimental Procedures
SybII/ceb DKO mouse E17- E18 embryos were obtained and chromaffin cells
isolated and plated as described [3, 22]. Recombinant Semliki Forest Virus
was used to introduce SybII mutants into the cells after day 2 or 4 in culture
[3, 1]. Full-length rat SybII plasmid was a kind gift from Dr. Thomas Su¨dhof.
The SybII TMD . . . WWKNLKMMIILGVICAIILIIIIVYFST was extended at the
C-terminal end by addition of K, E, KK, EE, QQ, HH, VV, or GG amino acids.
All constructs were confirmed by DNA sequencing.
3.5.1 Whole-cell capacitance measurement
Whole-cell patch clamp experiments were performed 4-6 hrs after transfection
at room temperature. The extracellular solution contained in mM: 145 NaCl, 1
MgCl2, 2.8 KCl, 2 CaCl2 and 10 HEPES pH 7.2, adjusted to 310 mOSM with D-
glucose. The whole-cell pipette solution contained in mM: 0.4 fura-4F, 0.4 mag-
fura-2 (Invitrogen), 5 Nitrophenyl-EGTA (NP-EGTA, Synaptic Systems), 100 Cs-
glutamate, 0.3 Na-GTP, 2 Mg-ATP, 4 CaCl2, 1 ascorbic acid and 32 HEPES, pH
7.2. Photolysis of NP-EGTA was achieved by a UV flash lamp (Rapp Optoelek-
tronik). Intracellular calcium measurements were performed by alternating the
fura-4F/mag-fura-2 excitation wavelength between 350 nm and 380 nm as de-
scribed [27]. Capacitance changes were measured using an EPC9 using the
“sine + dc” technique [14]. The amplitude of the exocytotic burst was taken as
the capacitance increase 500 ms after the flash. The sustained phase of exocyto-
sis was quantified as the capacitance increase over the next 5 s. Amperometric
recordings were performed with homemade 10 mm carbon fiber electrodes us-
ing an EPC7 amplifier and filtered at 3 KHz.
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3.5.2 Total Internal Reflection Fluorescence (TIRF) Microscopy
An inverted microscope (Axiovert 135 TV, Zeiss, Thornwood, NY) modified for
TIRF microscopy as described [2] and fitted with a Zeiss plan-fluar 1.45 NA
100x oil emersion objective was used to observe the cells during experiments.
Illumination was provided by a 100 W mercury arc lamp (HBO 103W/2, Osram,
Danvers, MA), with 480/40 nm excitation filter, 515 nm dichroic, and 520 nm
long pass emission filter (Chroma Technology, Rockingham, VT). Images were
collected using an EMCCD camera (Andor iXon, South Windsor, CT) and its
accompanying software. For each cell, a 2000 frame image sequence was col-
lected. The exposure time for each frame was 100-150 ms, with an interframe
time of 1.8 ms.
3.5.3 Electrochemical Detector Arrays
Microfabricated platinum electrode arrays were used to amperometrically de-
tect the release of catecholamines from the transfected chromaffin cells. Each
electrochemical detector (ECD) array consists of a set of four planar Pt elec-
trodes fabricated on a glass coverslip. The four electrodes of an ECD reside at
the corners of a square sized such that a cell can be placed atop the array and
viewed through the glass coverslip while amperometric currents are recorded
from all four electrodes simultaneously. The ECD arrays were fabricated as de-
scribed (Dias et al., 2002; Hafez et al., 2005) except for an improved insulation
layer, which was created by chemical vapor deposition of approx. 300 nm of
SiO2 onto the electrodes (IPE 1000 PECVD), and subsequent etching of the SiO2
layer via reactive ion etching (PlasmaLab 80Plus, Oxford Instruments, Concord,
MA) to expose the active areas of the electrodes and contact pads.
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3.5.4 Combined TIRF microscopy and ECD amperometry
GFP was linked to the N-terminus of SybII, SybII-KK, or SybII-EE and the con-
structs expressed in wild-type mouse chromaffin cells or in embryonic DKO
chromaffin cells as described above. Cells expressing the construct were located
using a 20x Zeiss air objective under epifluorescence illumination. Cells cho-
sen for experiments had a characteristic green GFP fuorescence, and exhibited
a concentration of the label in the ER. The cells of interest were also inspected
under bright field illumination to insure healthy cells were chosen. Cells were
picked up and positioned on the ECD arrays using a micropipette as described
[11]. TIRF microscopy (see above) was performed simultaneously with mea-
surement of catecholamine by amperometry using the ECD array as described
[11] . Amperometric currents were low pass filtered at 500 Hz, acquired with
5 kHz sampling rate and analyzed as described [11]. For analysis, a 5 pA min-
imum current peak height was used as threshold, with a minimum of four an-
alyzable events per cell. The camera output signal was recorded in order to
synchronize the timing of the fluorescence image frames with electrochemical
signals.
3.5.5 Assignment of free energies of transfer from water to mem-
brane interface
The whole residue transfer energies from water to the membrane interface of the
residues added to the C-terminus were taken from [31] [Table 3.5.5]. For Lys
the value in the table was used. The double additions LysLys, GlnGln, GlyGly,
and ValVal were assigned twice the values in the table. Assuming a pK of 4.3
for glutamic acid and an intravesicular pH of 5.5, one would expect 94% in Glu−
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and 6% in Glu0 state. We thus assigned a transfer energy for single Glu addition:
∆Gwi f = 0.94 × (2.02 ± 0.11(+0.06 × (−0.01 ± 0.15) = 1.90 ± 0.11kcal/mol.
For the GluGlu addition, ∆Gwi f could be twice that value (∆Gwi f = 3.8 ±
0.22). However, it appears possible that a negative charge on one Glu will sig-
nificantly change the pK of the second Glu, which may thus lead to ∼50% proto-
nation between the two added Glu residues corresponding to ∆Gwi f = 2.01±0.26.
For GluGlu we thus estimate a range∆Gwi f = 1.75 − 4.0 or 2.9 ± 1.1kcal/mol.
Assuming a pK of 6.0 for histidine one would expect 76% in His+ and 24% in
His0 state. We thus assigned a transfer energy for a single His addition:
∆Gwi f = 0.76 × (0.96 ± 12) + 0.24 × (0.17 ± 0.06) = 0.77 ± 0.11kcal/mol.
For the HisHis additon, ∆Gwi f could be twice that value (∆Gwi f = 1.54 ±
0.22). However, protonation of the first His may shift the pK of the second His
such that there could again be an average ∼50% protonation giving ∆Gwi f =
1.13±0.18. For HisHis we thus estimate a range ∆Gwi f = 0.95−1.76 = 1.35±0.41.
Due to these uncertainties the data points for sybII-HH and sybII-EE were not
included in the fits of Fig. 3.5 A.
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Table 3.2: Selected whole residue transfer energies from water to membrane in-
terface from [31].
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CHAPTER 4
MODULATION OF SYNAPTOBREVIN-2 FUNCTION BY GFP TAGS IN
CHROMAFFIN CELLS EXOCYTOSIS
4.1 Abstract
The green fluorescent protein (GFP) and its variants are commonly used to tag
proteins in order to trace their localization or to follow their activities. GFP was
previously linked to the vesicular protein synaptobrevin-2 to allow the visu-
alization of vesicles fusion and recycling. However, it is unclear whether the
hybridization of synaptobrevin-2 hinders its functionality in chromaffin cells.
Here we study whether the linked proteins, GFP-synaptobrevin-2 and synapto-
pHluorin can support calcium dependent exocytosis in chromaffin cells.
4.2 Introduction
Exocytosis is a process by which cells secrete their contents into the extracel-
lular space. Many proteins regulate this process, among which is the vesicu-
lar protein synaptobrevin-2 (or VAMP), a member of the SNARE (Soluble N-
ethylmaleimide-sensitive-factor Attachement protein REceptor) family.
Synaptobrevin-2 has three distinct regions, (i) a SNARE domain which forms a
complex with syntaxin and SNAP-25 to drive fusion [11], (ii) a transmembrane
domain (TMD) which is integrated into the bilayer membrane of vesicles [10],
and (iii) an unstructured linker region that forms a bridge between the SNARE
domain and the TMD [Fig. 4.2 A] [2].
pHluorin [7] is a histidine based mutation of the green fluorescent pro-
tein (GFP), whose fluorescence spectrum change as a response to the change
in pH of its environment. When pHluorin is linked to the C-terminal end of
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synaptobrevin-2 (synapto-pHluorin) and is targeted to the vesicle lumen
(pH∼5.6), its fluorescence is quenched due to the acidic pH [7]. However, upon
the fusion of the vesicle with the plasma membrane, the pHluorin is exposed
to the extracellular milieu (pH∼7.4), resulting to its fluorescence un-quenching.
Hence, by using synapto-pHlourin it has been possible to visualize exocytosis
[7, 15, 4, 8]. However, it is unclear whether synapto-pHlourin can participate
in the SNARE complex formation and mediates the fusion of vesicles, since
synapto-phluorin is typically expressed in the presence of wild-type synap-
tobrevin. Here we expressed synapto-pHluorin in sybII/cellubrevin double
knock out (DKO) chromaffin cells and assessed it functionality by caged-calcium
flash photolysis and whole cell capacitance measurement.
4.3 Result
The fusion of vesicles in chromaffin cells was stimulated by the homogeneous
release of photoreleasable calcium in the whole-cell patch clamp configuration
[12]. The intracellular calcium concentration in cells was estimated by ratio-
metric measurements of the calcium dyes Fura-2 and Furaptra (Chapter II).
The fusion of vesicles in response to the calcium stimulation was detected by
the increase of the capacitance of the cell membrane, and the secretion of cate-
cholamines that accompanied fusion was measured by amperometry.
Synapto-pHluorin partially rescued exocytosis in DKO Chromaffin cells
Synapto-pHluorin was constructed by fusing pHlourin at the carboxyl-terminus
of synaptobrevin-2 (SybII) via a flexible linker (SGGSGGTGG) [7]. Synapto-
pHluorin with this linker has been utilized in many experiments to monitor
exocytosis in neuronal synapses [8, 7], suggesting that this construct should
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not inhibit exocytosis in chromaffin cells. We overexpressed synapto-pHluorin
in wild-type chromaffin cells using the Simliki Forest Virus expression system.
Although synapto-pHluorin was expected to be targeted to vesicles, a consider-
able amount was also expressed at the surface of the cell membrane [8]. Since
cells were bathed during the experiment in the bath solution with pH ∼7.3, the
fluorescence of synapto-pHluorins at the cells surface were dequenched, hence
cells expressing the synapto-pHluorin were identified by their green fluores-
cence. Synapto-pHluorin expression in wild-type cells displayed robust capaci-
tance and amperometric responses [Fig.4.1 B], indicating that the fusion of vesi-
cles was not inhibited as expected [7, 15, 4, 8].
It is possible that in this experiment, exocytosis was mediated by both the
endogenous synaptobrevin and synapto-pHluorin, or exclusively or predomi-
nantly by synaptobrevin. To distinguish between these possibilities, synapto-
pHlourin was expressed in DKO embryonic chromaffin cells. DKO cells lacked
both synaptobrevin and cellubrevin (DKO) because these proteins are function-
ally interchangeable in chromaffin cells [2]. When these null cells were stim-
ulated by photorelease of calcium, the capacitance trace showed no exocytotic
response [Fig.4.1 C, green]. However, when the cells expressed SybII and GFP
as separate proteins, the capacitance amplitude rose to nearly ∼200 fF at 5 s af-
ter the stimulus was given, indicating that the exocytotic response was rescued.
Surprisingly, when synapto-Phluorin was expressed in these DKO cells, the ca-
pacitance amplitude was recuded by ∼70 % of SybII capacitance at 5 s. How-
ever, synapto-pHluorin expressing cells gave a capacitance amplitude that was
significantly higher than that observed in null cells [Fig.4.1 C], indicating that
synapto-pHluorin was able to rescue exocytosis in DKO cells at sub-optiomal
level.
The capacitance response to flash induced exocytosis displays a burst phase,
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which reflects the fusion of vesicles that have established a stable link with the
plasma membrane through SNARE complex formation prior to the elevation of
[Ca2+]i [9]. The burst was extracted by quantifying the change of the capaci-
tance amplitude at 0.5 s after flash stimulation [Fig.4.1 C]. When we compared
the burst amplitude, we observed that it was reduced for the synapto-pHluorin
construct [Fig.4.1 D]. Scaling the burst phase revealed that its kinetic was slower
than in SybII expressing cells [Fig.4.1 E]. Thus synapto-pHluorin decreased the
amount of vesicles fusing during the exocytotic burst phase and also slowed
down the kinetics of fusion.
The capacitance trace also displays a slower or sustained phase which has
a time constant of seconds. This phase has been attributed to vesicles under-
going functional maturation as long as the intracellular calcium concentration
remained high [13]. The sustained phase was quantified by taking the differ-
ence of the capacitance amplitude from 0.5 to 5 s. When cells expressed synapto-
pHluorin, the sustained phase was reduced in comparison to control [Fig.4.1 D],
indicating that synapto-pHluorin considerably slows down vesicle priming.
GFP-synaptobrevin-2 partially supports exocytosis
To determine whether the N-terminal fusion of GFP to synaptobrevin-2 also in-
hibits exocytosis, we engineered GFP-synaptobrevin-2 by fusing the fluorescent
protein GFP, to the amino-terminus of SybII (GFP-SybII) [Fig.4.2, A] . The con-
trol experiment consisted of the co-expression of GFP with SybII protein. Cells
co-expressing GFP and SybII proteins, showed diffuse fluorescence whereas
those infected with GFP-SybII virus showed localized fluorescence [Fig.4.2, B],
suggesting the accumulation of GFP-SybII proteins in the endoplasmic reticu-
lum.
As we have seen in Chapter III, the expression of wild-type SybII in null
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Figure 4.1: Synapto-pHluorin partially rescued secretion in DKO chromaffin
cells. (A) Synapto-pHluorin was constructed by fusing pHluorin to
the C-terminal end of synaptobrevin-2 protein via a linker region.
(B) The expression of synapto-pHluorin in the presence of endoge-
neous SybII protein shows a robust secretion. (C) Rescued experi-
ments showing a reduction the capacitance trace (middle panel) of
DKO cells expressing synapto-pHluorin (red, n=16) in comparison
to cells expressing SybII ( black, n=14) and DKO cells (green, n=25).
(C) Burst and sustained phase of the capacitance trace is reduced in
mutant cells.
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cells resulted in a two-phase increase of the capacitance trace [Fig.4.2, black
trace], indicating that the exocytotic phenotype was rescued. However, when
the GFP-SybII construct was expressed in null cells, the mean capacitance am-
plitude was reduced in comparison to the capacitance amplitude recorded in
control cells [Fig.4.2], red trace]. This was consistent with the reduction of the
amperometric current [Fig.4.2, bottom], indicating that fewer vesicles under-
went exocytosis in cells expressing GFP-SybII.
When we compared the burst amplitudes, we observed that this phase was
apparently reduced for the GFP-SybII construct, albeit not significantly [Fig.4.2
C], and scaling this region, did not show a difference in the kinetics in compari-
son to control. Thus, the GFP linked to SybII at the amino-terminus has little, if
any effect on the exocytotic burst. The sustained phase on the other hand, was
significantly reduced in comparison to the control [Fig.4.2 D], indicating that
amino acid terminal GFP tag considerably slows downs the priming of vesicles.
4.4 Discussions
There is considerable evidences that the TMD of synaptobrevin-2 plays an im-
portant role in neurotransmitter secretion during exocytosis. For example, mu-
tating key amino acids in the TMD of synaptobrevin-2 hinders its dimeriza-
tion in vitro [6] and impaired exocytosis (Chapter VI). Furthermore, it has been
found that lengthening the linker domain [5, 3] or adding extra residues at the
C-terminal end of synaptobrevin-2 (Chapter III) inhibits exocytosis.
Synapto-pHlourin which is constructed by joining pHluorin to the carboxyl end
of synaptobrevin-2, has been used to visualize vesicles secretion [7, 15, 4, 8],
suggesting that synapto-pHluorin is functionally competent to mediate exocy-
tosis.
67
60pA
40
20
0
I A
m
p
543210
Time (s)
20pC
10
0
Q
Am
p
200fF
150
100
50
0
Ä
C
m
60µM
40
20
0
[C
a2
+ ]
 
SybII(n=30)
GFP-SybII (n=12)
Flash
Slow Phase
Fa
st
 P
ha
se
  A
1.0
0.5
0.0S
ca
le
d 
Tr
ac
es
1.00.5
Time (s)
100fF
50
0
Burst Sust.
*
  B
  C
 E
 D
20
0
10
0
0
3002001000
5 ìm
10
0
50
0
150100500
SybII+GFP GFP-SybII
SNARE DOMAIN Linker TMDGFP
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tudes taken at 0.5 s after the calcium stimulus.
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However, these experiments were conducted in the presence of the en-
dogenous synaptobrevin-2. We have looked at vesicle secretion in chromaf-
fin cells by expressing synapto-pHluorin in the presence of the endogenous
synaptobrevin-2, and our result demonstrates that exocytosis is also not inhib-
ited in this system. However, when cells are devoid of the endogenous pro-
teins, synapto-pHluorin fails to entirely rescue exocytosis, thus suggesting that
synapto-pHluorin is unable to compete with synaptobrevin in cells expressing
both proteins. In the absence of the endogenous SybII and cellubrevin, synapto-
pHluorin supports exocytosis but the amplitude of exocytosis is inhibited by
∼ 70%. The C-terminal one or two amino acid additions inhibit exocytosis
depending on the energy of transfer from water to the membrane interface
(∆Gwi f ) of the added residues following a Boltzmann distribution (Chapter III).
In synapto-pHluorin, an SGGSGGTGG linker is used, thus the transfer of this
linker into the water-lipid membrane interface may have induce the exocytotic
inhibition.
The priming of vesicles entails in part the formation of the N-terminal do-
main of the complex formed by syntaxin, SNAP-25 and synaptobrevin [9, 14].
We have observed that GFP-SybII hinders vesicle priming, consistent with the
notion that the GFP protein at the amino-terminal end of SybII may hinder the
association of synaptobrevin with syntaxin and SNAP-25, thus obstructing with
the formation of the SNARE complex. However, since we also have observed
that GFP-SybII proteins were mainly located into the endoplasmatic reticulum,
it is also possible that after the synthesis of GFP-SybII proteins by the ribosome,
the proteins are missorted and as result, fewer GFP-SybII proteins could end up
on their target vesicles.
Contrary to the results that we have reported here, fusing the GFP vari-
ants, Venus and eCFP at animo or carboxyl-terminus of synaptobrevin-2 does
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not inhibit synaptic function in synaptobrevin-2 knock-out neurons [3]. This
discrepancy could be due to the difference in experimental procedures. How-
ever to be able to draw any definitive conclusion, more results are clearly needed.
4.5 Methods
GFP-synaptobrevin-2 was engineered by amplifying synaptobrevin-2 by PCR to
generate a 5’ XhoI and 3’ KpnI site. Then it was inserted into the XhoI/KpnI site
of the pEGFP-N1 (Clontech), yielding GFP-synaptobrevin. Synapto-pHluorin
a generous gift from Dr. Jurgen Klingauf, was amplified by PCR and DNA
sequenced. The Cells were infected for 6 h using the Semliki Forest Virus ex-
pression [1] to allowed the expression of GFP-synaptobrevin-2 and synapto-
pHluorin. To minimize the experiment variabilities, cells from the same animal
were plated onto different coverslips and were incubated for 6 hours with SybII
wild-type virus or with the hybridized SybII virus . Only the control (SybII
wild-type) and the hybridized SybII data acquired from the same animal were
considered for statistical analysis. Fluorescent cells were imaged by using bright
field illumination microscopy with a 40X objective. The acquisition and the
analysis of the electrophysiology data were carried out as previously described
(Chapter III).
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CHAPTER 5
ON THE IMPORTANCE OF SYNAPTOBREVIN-2 FOR THE FLUX OF
NEUROTRANSMITTERS THROUGH THE FUSION PORE
5.1 Abstract
Neurotransmitters are stored in vesicles and are secreted into the extracellular
space through a fusion pore. In SNARE mediated exocytosis, it has been specu-
lated that the fusion pore is formed by the syntaxin transmembrane domain and
potentially that of synaptobrevin-2. Here, we have introduced charged amino
acids at position 113 of the synaptobrevin-2 transmembrane domain, close to its
C-terminus. We have expressed the mutated proteins in synaptobrevin-2 and
cellubrevin double knocked out (DKO) embryonic chromaffin cells and have
studied whether these mutations can support exocytosis by using a combina-
tion of whole-cell calcium flash photolysis and amperometry measurements.
We find that the mutated proteins partially rescued exocytosis, and significantly
reduced the flux of neurotransmitters through the narrow fusion pore, thus sug-
gesting that synaptobrevin-2 transmembrane domain is located in the fusion
pore.
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5.2 Introduction
The assembly of the SNARE proteins, namely that of the synaptosome associ-
ated protein of 25 KD (SNAP-25), syntaxin and synaptobrevin/Vamp (SybII)
bridges the apposing membrane of the vesicle and the cell plasma membrane
to drive calcium dependent exocytosis [19, 20, 16, 17]. Prior to full vesicle fu-
sion, the SNARE proteins assemble into a complex thereby driving the forma-
tion of the fusion pore through which molecules can channel into the extracellu-
lar space [18, 11]. The fusion pore can expand to a diameter exceeding 3 nm [1],
which allows neurotransmitters to diffuse out of the vesicle with a time course
of few milliseconds [22, 11]. Even though the exact molecular composition of
the pore is unclear, it is becoming evident that the SNARE proteins C-terminal
domains modulate its structure.
The deletion of the last nine residues of SNAP-25 elongates the early fusion
pore [5], and mutagenesis of the transmembrane domain (TMD) of syntaxin re-
duces the flux of neurotransmitters through the narrow fusion pore [6, 7]. From
this latter result, it has been suggested that the syntaxin TMD lines the fusion
pore. Since syntaxin and synaptobrevin-2 are both embedded into apposing
lipid bilayers prior to exocytosis, and both mediate the formation of the pore, it
is proposed that synaptobrevin-2 may also line the fusion pore [9].
However, direct evidence backing up this claim is still lacking, nonethe-
less, studies have shown that exocytosis is affected when the synaptobrevin-2 C-
terminal region is altered [10, 13]. In particular, lengthening the flexible region
that separates the cytosolic domain of synaptobrevin-2 to its TMD, reduces vesi-
cles priming, and delays exocytosis [10]. Furthermore, adding charged residues
at the C-terminal end of synaptobrevin-2 inhibits exocytosis (Chapter III). Based
on these experimental observations, the synaptobrevin-2 TMD should receive
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further attention. To investigate whether the introduction of charged residues
into the synaptobrevin-2 transmembrane domain, near the C-terminus have any
effect on exocytosis, we used a combination of capacitance and amperometry
measurements.
5.3 Results
The TMD of synaptobrevin-2 (SybII) is composed of mostly hydrophobic residues
(aa 97-116). We mutated the amino acids tyrosine at position 113 to either a ly-
sine or a glutamate, because the alignment of SybII with its homologues vamp1
and the drosophila n synaptobrevin [Fig. 5.1 A] suggested that a charged residue
may be tolerated at position 113 of SybII. SybII mutations were reintroduced
into cells using the Semiliki Forest Virus expression system, and exocytosis was
triggered by infusing photoreleasable calcium at whole-cell patch. We cultured
chromaffin cells from double knocked out (DKO) embryonic adrenal gland de-
prived of synaptobrevin-2 (SybII) and cellubrevin. The DKO chromaffin cells
failed to express the exocytotic phenotype. However 4 h after SybII wild-type
protein expression, the secretion defect was rescued [Fig.5.1 B] as previously
observed (Chapter III).
5.3.1 The mutations SybII-Y113K and SybII-Y113E partially res-
cued vesicles fusion
Cells expressing SybII-Y113K and SybII-Y113E showed a reduction of the ca-
pacitance response in comparison to wild-type SybII [Fig.5.1 B]. The capacitance
trace typically displays a burst and a sustained phase. We compared the burst
amplitude of the mutated proteins to that of wild-type SybII by taking the ca-
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pacitance increase at 0.5 s post stimulus. The burst amplitude with SybII-Y113E
and with SybII-Y113K were ∼57% and ∼63% of that with wild-type SybII, re-
spectively [Fig.5.1 C].
After scaling the burst phase to the same amplitude, it was evident that the
glutamate mutation slowed down the burst kinetics, whereas the lysine did not
change the fusion kinetics [Fig. 5.1 D]. The sustained phase which is the slowest
component of the capacitance change was quantified by taking the difference in
capacitance amplitude between 0.5 and 5 s after the step wise calcium increase.
This phase was significantly reduced by ∼55% [Fig.5.1 C] for both SybII-Y113E
and SybII-Y113K [Fig. 5.1 B]. To rule out the possibility that the difference in
exocytosis amplitudes are due to the dissimilarity in protein expression lev-
els, SybII and its homologues were quantified by immunofluorescence. The
result shows that the SybII, SybII-Y113K and SybII-Y113E are expressed at sim-
ilar level after 4 hours of viral infection [Fig.5.2].
The differences in capacitance amplitudes of SybII-Y113K and SybII-Y113E
versus SybII at whole-cell patch-clamp configuration, could have been caused
by the change in individual vesicle sizes. Therefore, as a next step, we used
cell-attached capacitance measurement to determine the size of single vesicles.
Figure 5.1.E shows an example of a single vesicle capacitance step of 0.9 fF. The
small transient increase in the real part (Re) of the admittance is produced by the
low initial pore conductance. The capacitance increase (Cv) is calculated as Cv =
Re2+Im2
Im [12]. The mean±s.e.m capacitance step of embryonic chromaffin cells
expressing SybII (0.36±0.02 fF) was similar to that recorded in wild-type non in-
fected cells (0.38±0.03 fF). Also, cells expressing SybII-Y113K (0.34±0.04 fF) and
SybII-Y113E (0.35±0.03 fF) had comparable mean capacitance step sizes. As-
suming a specific vesicle membrane capacitance of 9 fF/µm [1], these mean ca-
pacitance step sizes correspond to vesicle diameters of 110-116 nm as expected
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Figure 5.1: (A) Sequence alignment of synaptobrevin-2 homologues VAMP1
and n synaptobrevin. The tyrosine residue at position 113 of
synaptobrevin-2 was mutated to a single lysine (SybII-Y113K) or
glutamate (SybII-Y113E). (B) Exocytosis was stimulated by photore-
leasable calcium and was monitored by the change of the cell mem-
brane capacitance and the release of catecholamine. At comparable
[Ca2+]i increase (top), cells expressing SybII-Y113K (n=17) and SybII-
Y113E (n=14) show reduced capacitance amplitudes (middle) and
amperometry currents (bottom) in comparison to wild-type SybII
(n=11). (C) The mutations reduced the burst and the sustained
phases of the capacitance change. (D) Scaled capacitance traces at
0.5 s after stimulus. (E) Example recording of a single vesicle step size
acquired at cell-attached patch configuration. (F) Wild-type of non
infected cells (n=21 cells,173 events), SybII expression (n=11 cells,
50 events), SybII-Y113K (n=14 cells, 52 events) and SybII-Y113E (n=11
cells, 79 events).
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from the size of granules in mouse embryonic chromaffin cells ∼130 nm [3].
5.3.2 Single vesicle amperometry characterization
Chromaffin granules contain catecholamine, which they release into the extra-
cellular space through the fusion pore. To detect these molecules, a carbon fiber
electrode was pressed down onto the cell membrane. The amperometry spike
currents [Fig.5.3 B] resulting from the oxidation of catecholamine molecules
at the surface of the electrode held at + 700 mV, provide information on the
amount, and kinetics of release of these molecules from individual vesicles.
We used the amperometry measurement to assess whether the residues SybII-
Y113K and SybII-Y113E altered the fusion pore properties.
Exocytosis was stimulated by infusing ∼10 µM free calcium into cells. On
average, ∼23 events/min were recorded from cells expressing the wild-type SybII,
with ∼15 and ∼17 events/min for cells expressing SybII-Y113K and SybII-Y113E
respectively. This reduction of the rate of single release events is consistent
with the reduction of capacitance amplitude at whole-cell patch-clamp [Fig.5.1].
In addition, the amount of catecholamine molecules released from the indi-
vidual vesicles, assessed as the integrated charged of ameperometry spikes,
were similar regardless of whether the cells expressed the wild-type or the mu-
tated proteins, SybII (0.33±0.03 pC), SybII-Y113E (0.30±0.04 pC), SybII-Y113K
(0.30±0.02 pC) [Fig.5.3 C]. The mean current amplitudes on the other hand dif-
fered, being lower (36.99±4.54 pA) and (22.12±2.40 pA) for SybII-Y113K and
SybII-Y113E respectively, in comparison to (56.60±6.19 pA) for wild-type SybII
[Fig.5.3 D]. The decrease in spike amplitude was accompanied by an increase in
spike half width [Fig.5.3 E]
These results indicate that SybII-Y113K and SybII-Y113E slow down the
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Figure 5.2: Synaptobrevin-2 isoforms quantification in embryonic mouse chro-
maffin cells. (A) Cells were immunostained with antibodies against
SybII, those that were also successfully infected with viral particles
and identified by their eGFP expression were selected for analy-
sis. Exemplary fluorescent cells, wild-type non infected (WT+/+),
cells overexpressing SybII, SybII-Y113K and SybII-Y113E. (B) Pro-
tein quantification using epifluorescence microscopy. SybII, SybII-
Y113K and SybII-Y113E were overexpressed ∼4 fold more than
wild-type control (WT+/+) (>n=20 cells, 3 preparations, scale bar 5
µM). (C) The confocal images of WT+/+, SybII, SybII-Y113K, SybII-
Y113E stained with sybII- antibody are granulated and in some
cases the granules appear to circumvent the nucleus, indicating the
synaptobrevin-2 were located in the vesicles.
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release of catecholamine molecules from individual vesicles during the amper-
ometry spike phase. The amperometry spike is often preceded by an amper-
ometric foot current that reflects the formation of a metastable narrow fusion
pore, which allows for a slow leakage of molecules from the vesicle. If the TMD
of SybII is located at the mouth of the fusion pore or inside the fusion pore, the
charged residues at position 113 may alter the flux of catecholamine. Therefore,
we determined the foot current properties. The mean foot duration [Fig.5.3 F]
was longer for SybII-Y113K (5.46±0.46 ms) and SybII-Y113E (7.27±0.42 ms), al-
beit only the value for SybII-Y113E was significantly different from wild-type
SybII (5.03±0.34 ms). In addition, the foot current amplitudes were signifi-
cantly smaller [Fig.5.3 G], indicating a slow flux of catecholamine molecules
through the fusion pores of cells expressing the mutants proteins SybII-Y113E
(0.021 ±0.002 pC) and SybII-Y113K (0.0171±0.002 pC), in comparison to SybII
(0.032±0.003 pC).
Fusion pores exhibit dynamic fluctuations that lead to corresponding fluc-
tuations in amperometric foot current. To determine if the foot currents are
modified by the mutants SybII-Y113K and SybII-Y113E, we analyzed the fluc-
tuations in the foot amperometry current. The example in Fig.5.4 A, the initial
foot current amplitude is ∼ 3.65 pA, and the foot current rises with a slope of
∼ 138.39pA/ms, where the slope of the foot current reflects the fusion pore
expansion, and the initial foot current amplitude indicates the initial fusion
pore conductance. Cells expressing SybII showed an initial foot current of 1.85
±0.31 pA, whereas cells with the mutated proteins had a significant reduction
of initial foot current of 0.65 ±0.18 pA, and 0.62 ±0.31 pA for SybII-Y113E and
SybII-Y113K respectively [Fig.5.4 B]. The foot slope on the other hand, was
similar for cells expressing SybII 873.14±60.12 pA/s (n=241 events) and those
expressing SybII-Y113K 734.07±149.33 pA/s (n=128 events). Whereas the foot
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Figure 5.3: Charged residues at position 113 in the TMD of synaptobrevin-2 al-
tered the fusion pore properties. (A) Sample amperometry trace
recording from cells expressing wild-type SybII (top), SybII-Y113E
(middle) and SybII-Y113K (bottom). (B) Representation of a sin-
gle spike taken from SybII trace, with spike parameters as indi-
cated (Foot current, half-width, quanta charge, foot duration, and
spike amplitude). (D-H) The mean±s.e.m of >10 pA spikes proper-
ties, SybII-Y113E (n=17) and SybII-Y113K (n=17) and SybII (n=18)
*P<0.05, **P<0.01.
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slope for cells expressing SybII-Y113E (521.83±43.48 pA/s, n=216 events), was
significantly slower than that for wild-type SybII [Fig.5.4 C].
The foot current deviates somewhat from its mean values during the foot
current expansion [Fig.5.4 A], presumably reflecting the conductance property
of the fusion pore at different times. The fluctuation of the foot current [Fig.5.4
D] were obtained by taking the difference between the actual foot current and
its best linear fit [straight red line in Fig.5.4 A].
The variance, which was obtained by squaring the amplitudes of the resid-
ual current, increase with higher foot current amplitudes for cells expressing
SybII. Whereas the variances of cells expressing the mutants proteins had smaller
amplitudes and deviated less from their mean foot currents [Fig.5.4 E]. The
power spectrum did not shows any preferred frequency, indicating that the cur-
rents fluctuated stochastically [Fig.5.4 F]. Furthermore, only the fluctuation am-
plitudes of cells expressing SybII-Y113E were apparently smaller than that of
cells expressing SybII-Y113K and SybII.
5.4 Discussion
To achieve a rapid and effective neurotransmitter release, SNARE proteins pre-
assembled into a complex [19, 20, 8] thus providing energy for the apposite
membranes to merge, and thereby inducing the fusion pore formation.
Synaptobrevin-2 modulates the fusion pore in synaptic vesicles and in chro-
maffin cells by means of its TMD [19, 14] (Chapter III, IV). We have previ-
ously established that the C-terminal end of synaptobrevin-2 disrupts the lipid
bilayer continuity to initiate the fusion pore through which neurotransmitters
are release into the extracellular space. However it was still unclear whether
synaptobrevin-2 TMD is located in the fusion pore during the pore expansion.
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Figure 5.4: Foot current fluctuation analysis. (A) Example of a fluctuating foot
current. The mean current was obtained by fitting the foot with a
straight line (red line). From the fit, the initial foot current and the
slope of the foot can be extracted. (B-C) Initial currents and foot cur-
rent expansion rate of cells expressing SybII, SybII-Y113K and SybII-
Y113E. (D) The residual current was obtained by taking the difference
between the foot current and the linear fit. (E) Foot current variance
plotted against mean current. (F) Power spectrum of wild-type SybII
control, SybII-Y113K, SybII-Y113E (dot).
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Here, we have introduced a single lysine or glutamate in the TMD of synapto-
brevin-2, near the alleged location of the pore, this resulted in a significant re-
duction of the exocytotic amplitude at whole-cell patch.
By using single vesicle capacitance measurement, we excluded the pos-
sibility that this reduction of the total cell membrane area was due to the dif-
ference in the size of the vesicles. Thus it seems likely that these mutations
partially inhibit exocytosis by rendering fewer vesicles fusion-competent. This
phenotype was also confirmed by lower frequencies of observable single vesi-
cles fusion found with the mutations.
5.4.1 Synaptobrevin-2 transmembrane domain modulates the
fusion pore conductance
As vesicles fuse with the plasma membrane, a narrow fusion pore that allows
for the flux of catecholamine into the extracellular space is formed. Charged
residues in the TMD of synaptobrevin-2 if facing the fusion pore, may inter-
fere with this migration because the released catecholamines carry a positive
charge. In this frame work, we analyzed the catecholamine release during the
first milliseconds of the fusion pore existence. Interestingly, the positively and
the negatively charged mutants, SybII-Y113K and SybII-Y113E both led to a sig-
nificant reduction of the amount of catecholamine molecules detected during
the initial fusion pore expansion, indicating that the transmembrane domain of
the mutated proteins interfere with the flux of catecholamine molecules.
It has also been reported that the TMD of synaptobrevin-2 lays at a tilt
angle with respect to the vertical in the lipid bilayer [4]. Thus, the side chains
of the lysine and glutamate residues at position 113 near the bilayer interphase
may “snorkel” into the lipid head groups region to accommodate the charges on
85
the side chains while the hydrocarbons of the amino acids remained inside the
lipid membrane. In this new configuration, the fusion pore structure may have
been altered and synaptobrevin-2 transmembrane domain may have placed the
charged side chains inside the fusion pore, leading to a reduction of the initial
foot current as observed in [Fig.5.4, B].
Since the catecholamine molecules are positively charged at neutral and
acidic pH, they may have interacted electrostatically with the charges on the
side chains of the lysine or the glutamate residues during their passage through
the narrow fusion pore, which may have led to fewer molecules being released
during fusion pore expansion [Fig.5.3 H]. More importantly, the reduction of
catecholamine molecules through the narrow fusion pore strongly suggests that
synaptobrevin-2 C-terminal region is located in the fusion pore. A similar obser-
vation was previously reported when selected residues of the TMD of syntaxin
were mutated to ionizable side chains [6, 7].
We observed that the foot current expansion rate is significantly slower
for the negatively charged mutant and not for the positively charged mutant
[Fig.5.4 D]. This is consistent with slower kinetic of vesicles fusion observed by
scaling the burst phase of the capacitance increase [Fig.5.1 D], and the lower
amplitude of frequencies observed in the power spectra. This suggest that the
fusion pores formed by the negatively charged transmembrane domain slow
down the fusion pore expansion rate. The specific reason for this phenotype
is not yet well understood. Nevertheless, it is conceivable that, the glutamate
being negatively charged would attract the positively charged catecholamines,
and in the process may bind to them, thereby inducing a steric occlusion of the
fusion pore and slowing down the movement of the transmembrane domain
of synaptobrevin-2 (Chapter III). It is, however also possible that the structure
of SybII TMD in the fusion pore is affected because the positive charge of the
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lysine my accommodate better in the lipid head groups region than the negative
charge of the glutamate. Also the potential snorkel for lysine is much longer
than for glutamate.
5.5 Methods
5.5.1 Single Cell expression
Single chromaffin cells were isolated by enzymatic reaction from the medulla
gland of E17-E19 embryonic littermate lacking both synaptobrevin-2 and cellu-
brevin. The cDNA encoding for SybII-Y113E and SybII-Y113K were produced
by polymeric chain reaction (PCR) and verified by cDNA sequencing. Cells
were infected after 3 to 4 days in cultures using the Semliki Forest Viral expres-
sion system [2].
5.5.2 Electrophysiology
Individual chromaffin cells were infected for 4 or 5 h to allow for the dual ex-
pression of eGFP and synaptobrevin-2. The flash photolysis and the capacitance
measurement were carried at whole-cell patch configuration by infusing 0.4 M
fura-4F, 0.4 M mag-fura-2 (Molecular Probes, Eugene, OR) and 0.4 M CaCl2
bound to 0.5 M Nitrophenyl-EGTA . The ratiometric fluorescent measurement
for calcium detection were performed as previously described [21]. Single vesi-
cle capacitance was obtained at cell-attached patch configuration. The bath so-
lution contained in mM: 145 NaCl, 1 MgCl2 , 2.8 KCl, 2 CaCl2 and 10 HEPES.
The pH and osmolarity was adjusted to 7.2 with NaOH and to 310 mOSM
with D-glucose whenever necessary. The pipette solution contained in (mM)
50 NaCl, 100 TEA-Cl, 5 KCl, 5 CaCl2, 1 MgCl2, and 10 Hepes/NaOH (pH 7.2).
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The experiments were performed using the EPC-7 amplifier (HEKA) and the
lock-in amplifier (SR 830; Stanford Research Systems). A 20-KHz at 50 mV sine
wave stimulus at 100 mV/pA was used to resolve the single capacitance steps.
The phase was calibrated offline for each recording by using Igor Pro software
(Wavemetrics, Lake Oswego, OR).
5.5.3 Amperometry
The high resolution amperometry measurement was used to detect the secretion
of molecules from individual vesicles. The conventional carbon electrode with a
10 µM fiber diameter was used. To minimize the error due to diffusion, the car-
bon fiber was pressed onto the cell membrane and the tip of the electrode was
cut before each experiment. The oxidation of molecules at surface of the elec-
trode was detected as an amperometry spike and was acquired with EPC7 and
filtered with 3 kHz with a sampling frequency of 20 kHz. To stimulate exocyto-
sis, the cells were infused at whole-cell configuration with a solution containing
in (mM) 100 Cs-glutamate, 0.3 Na-GTP, 2 Mg-ATP, 2.5 CaCl2, 0.4 fura-4F, 0.4 fu-
raptra, 20 DPTA and 32 HEPES, pH 7.2. The data are the mean of the median
and One-way ANOVA was used for statistical analysis (*P<0.05, **P<0.01).
The foot current I f oot is proportional to the the flux J of neurotransmitters
through the narrow fusion pore (5.1) [15].
I f oot ∝ J =
pi · R2pore · D · ∆C
Lpore
(5.1)
Where ∆C is the difference of neurotransmitters concentration between the
interior and the exterior of the vesicle, D is the diffusion coefficient, R2pore, the
radius and Lpore, the fusion pore length. Foot currents longer than 10 ms were
obtained by fitting the foot trace I f oot with a line Imean (5.2).
88
Imean(t) = A · (t) + Imean(0) (5.2)
Where A is the amplitude of the foot and Imean(0) the initial foot current.
The residual current Iresidual was obtained by subtracting the I f oot from Imean(5.3).
Iresidual(t) = I f oot(t) − Imean(t) (5.3)
The variance was obtained by taking the squared amplitude of the resid-
ual current, and the power spectrum was obtained by taking the square of the
Fourier transform of the residual current.
5.5.4 Immunofluorescence
Embryonic chromaffin cells were fixed after 4 h of viral infection with 3.7%
formaldehyde for 20 min at room temperature. Cells were subsequently washed
in phosphate-buffered saline (PBS), permeabilized for 10 min in 0.1% triton X-
100 and quenched with 50mM NH4Cl. The cells were then incubated for 2 h
with the monoclonal primary antibodies ( mouse anti-synaptobrevin-2) diluted
1:500 in 10% bovine serum albumin (Synaptic Systems, Go¨ttingen, Germany )
followed by 10 min wash in PBS. They were then exposed to the secondary an-
tibody (cyanine (Cy)3-conjugated goat anti-mouse dilutions 1:200) for an 1 h at
room temperature. Cells expressing the eGFP were chosen for synaptobrevin-2
proteins level quantification, using bright field illumination microscopy (Imag-
ing Facility, Life Science Core Laboratiories Center, Cornell University) with ex-
citation filter 560/55 and emission 645/75. The intensity of the region of interest
was computed and subtracted from intensity of the local background. An aver-
age of 2-3 animals was used for this study. Confocal images were acquired using
Leica confocal microscopy TCS SP2 with a 40x (NA 0.8/W.D. 3.3 mm) dipping
objective.
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CHAPTER 6
SYNAPTOBREVIN-2 DIMERIZATION IN CHROMAFFIN CELLS
6.1 Abstract
The exocytosis of neurons and neuroendocrine cells is driven by the formation
of tight helical bundle. This complex is formed by the interaction of synaptobrevin-
2, syntaxin and SNAP-25, and it mediates exocytosis by bringing the vesicle and
the cell membranes in close apposition. Synaptobrevin-2 is anchored to the vesi-
cle membrane by a transmembrane region. Invitro, this domain can self-interact,
thus inducing the dimerization of synaptobrevin-2. However the physiologi-
cal relevance of synaptobrevin-2 dimers has been questioned. Here we investi-
gate whether the mutants L99A, C103A and I111A that inhibit synaptobevin-2
dimerization can support calcium dependent exocytosis in chromaffin cells. We
find that, while the single point mutation L99A, and the double point muta-
tion C103A/I111A partially rescue exocytosis in comparison to the wild-type
synaptobrevin-2, the triple point mutant L99A/C103/I111A nearly abolishes
secretion. We also find that the mutant C103N implicated in the increase of
synaptobrevin-2 dimerization, also fails to rescue the exocytotic phenotype. Base
on kinetic analysis, we infer that these defects are primarily due to the priming
defect of vesicles.
6.2 Introduction
The neuronal SNARE (soluble N-ethylmaleimid-sensitive factor (NSF) attach-
ment protein receptor) proteins play an important role in the release of neu-
rotransmitters. Neurotransmitters are compartmentalized into vesicles, and in
order to be released into the extracellular space, the vesicles dock and fuse with
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the cell plasma membrane. This process is mediated by the so-called SNARE
proteins, namely synaptobrevin, syntaxin and SNAP-25 [22, 15, 6, 9]. It has
been established by crystallography that these proteins form a coiled-coil struc-
ture [22, 20] in which synaptobrevin SNARE motif binds to a pre-complex
formed by syntaxin and SNAP-25 [7]. It has also been shown experimentally
that, when the SNARE complex is cleaved by toxins, vesicle secretion is abol-
ished in neurons and in chromaffin cells (view review [12]). Synaptobrevin
has been of interest in recent years because it is the only protein of the complex
which is anchored to the vesicle. In fact, synaptobrevin spans the vesicular bi-
layer through a single transmembrane domain (TMD). Although the function of
this domain remains elusive, it has been proposed, based on invitro assays that
synaptobrevin forms dimers [10, 11]. In SDS-PAGE assay, full length synapto-
brevin molecules pairs up with other synaptobrevin via the interaction of their
transmembrane domains. Three residues responsible for this interaction were
identified [10], when leucine at position 99 (L99), cystine at position 103 (C103)
and isoleucine at position 111 (I111) in the transmembrane domain were mu-
tated to the amino acid alanine, the ratio of dimer-to-monomer synaptobrevin
was significantly reduced [10] indicating that the protein lost its ability to form
dimers. Furthermore, when L99, C103 and I111 were grafted onto an otherwise
monomeric structure, this was sufficient to induce dimerization [11]. These ob-
servations suggested that, these three amino acids contained most of the dimers
packing interaction and led to the conclusion that, the TMD of the synapto-
brevin interacts via a set of selected residues, wherein amino acids facing each
other form a link via their side chain interactions. Although synaptobrevin
dimers have been detected in embryonic synaptosomes [1] the physiological
relevance of synaptobrevin dimers has been questioned [4]. Here we explore
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whether L99, C103 and I111 that have been previously identified to promote
dimerization invitro are relevant in supporting [Ca2+]i dependent exocytosis in
chromaffin cell. We find that these mutations hinder the priming step of exocy-
tosis.
6.3 Results
We studied whether replacing the residues L99, C103 and I111 [Fig.6.1] to ala-
nine supports exocytosis in cells. To this end, we generated synaptobrevin-
2 (SybII) constructs with either a single, double or triple mutations [Fig.6.1].
These mutants were expressed in E17-E19 embryonic chromaffin cells lacking
synaptobrevin-2 and cellubrevin (DKO). DKO cells were necessary because cel-
lubrevin can functionally substitute for SybII in this system [3]. Exocytosis was
stimulated by raising homogeneously the intracellular free calcium to ∼30 µm
by flash induced photorelease of caged Ca2+. Vesicle fusion was monitored at
whole-cell patch clamp by means of the cell membrane capacitance measure-
ment, which capacitance increase reflected the fusion of vesicles with the plasma
membrane. The capacitance measurement was combined with the detection of
catecholamine molecules secreted by the vesicles during fusion [Fig.6.2 A (bot-
tom panel)] [25]. We started by expressing SybII in DKO cells (data not shown),
as previously described (Chapter III), DKO cells did not show a significant in-
crease in membrane capacitance, whereas when they were infected by viral ex-
pression of wild-type SybII, the capacitance response was rescued.
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C103L99 I111
Figure 6.1: Mutations implicated in the dimerization of synaptobrevin-2 are
located in the transmembrane region of the protein. Full length
synaptobrevin-2 structure modified from 3IPD [20]. The residues
L99, C103 and I111 are in yellow.
6.3.1 The dimerization mutants L99A, C103A and I111A par-
tially inhibit exocytosis
The mutant SybII-I111A reduced SybII TMD dimerization invitro [10]. When
we expressed SybII-I111A in chromaffin cells, the average capacitance increase
at 5 s after stimulus [Fig.6.2 A (arrow)], was ∼52 % of the capacitance ampli-
tude recorded in cells expressing the wild-type SybII [Fig.6.2 A]. Introducing the
double point mutation SybII-L99A/C103A, showed similar inhibition of ∼43 %
[Fig.6.2 A,B]. The triple point mutation SybII-L99A/C103A/I111A further re-
duced the capacitance amplitude to nearly ∼23 % of control [Fig.6.2 C]. These
results suggest that the dimerization mutants that are implicated in inhibiting
SybII TMD dimerization, also inhibit the exocytotic response.
The capacitance response to a step-like calcium increase shows a rapid
burst phase which typically last ∼0.5 s after stimulus. This phase can be fitted
with the sum of two exponential functions [Fig.6.2 D], where the fastest kinetic
component reflects the fusion of the readily releasable pool (RRP) of vesicles,
and the slower component, the fusion of the slowly releasable pool (SRP) of
vesicles [23, 18, 26]. These pools reflect vesicles that have already undergone
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Figure 6.2: The expression of the dimerization mutants in chromaffin cells dis-
rupts the exocytotic phenotype. (A) The single point mutation SybII-
I111A (n=22), (B) the double point mutation SybII-L99A/C103A
(n=20), and (C) the triple point mutation SybII-L99A/C103A/I111A
(n=21) all display a reduction of the capacitance amplitude (mid-
dle), and amperometry current (bottom) in comparison to the control
SybII (middle, black) (n=30), at similar calcium level (upper traces).
(D) The kinetic parameters were evaluated by fitting the individual
capacitance traces with a triple exponential function (Method). Sam-
ple fits of wild-type (black) and SybII-L99A/C103A/I111A (green)
capacitance traces. (E-G) From the fit, we extracted the RRP and the
SRP. The RRP amplitudes are reduced in the mutants whereas, the
SRP amplitudes are similar to that of control SybII. Furthermore, the
time constants of the different pools are similar for the mutants and
the control. (F) Capacitance traces scaled at 0.5 s after the calcium
stimulus. (H) All mutants impaired the sustained phase significantly
(*P<0.05, **P<0.01, Student’s t-test).
98
the priming step at the onset of the calcium stimulus. The sum of exponential fit
yields multiple parameters, the amplitudes and the time constants. The ampli-
tudes reflect the sizes of the pools whereas the time constants indicate the kinet-
ics of fusion of their vesicles. Besides the burst phase, the capacitance response
also displays a sustained phase which typically last several seconds. This phase
reflects vesicles that replenish the SRP under the condition of sustained calcium
increase [18]. In our experiments, the dimerization mutants reduced the RRP
and the sustained phase amplitudes ( capacitance increase during 0.5 s to 5 s af-
ter the calcium stimulus ), while the SRP amplitudes remained constant [Fig.6.2
E,H]. However, the time constant of neither the RRP nor the SRP was affected by
the mutations [Fig.6.2 G] [Table 6.3.2]. This indicates that, although the dimer-
ization mutants affect the RRP sizes, they do not hinder the fast fusion of vesi-
cles with the plasma membrane. In addition, the reduction of the sustained
phase indicates that the amount of vesicles undergoing priming during the 5 s
of our data acquisition was reduced, suggesting a defect in the priming step of
vesicles.
6.3.2 Increasing synaptobrevin-2 dimerization inhibits calcium
dependent exocytosis
Given that we observed the inhibition of exocytosis with mutations implicated
in inhibiting SybII dimerization, we next investigated SybII-C103N, which was
reported to increase SybII TMD dimerization invitro by ∼ 14 fold [4]. The expres-
sion of SybII-C103N in cells also gave sub-optimal secretion as attested by the
reduction of the capacitance and the amperometry amplitudes [Fig. 6.3 A] com-
pared to cells expressing wild-type SybII. The RRP, SRP and sustained phase
amplitudes were all significantly smaller in comparison to wild-type SybII
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Figure 6.3: (A) The rescued experiment shows that the capacitance amplitude
is reduced by ∼69% ( middle, n=15) of wild-type (black,n=12), this
is consistent with the reduction in catecholamine released as visu-
alized by amperometry (bottom) trace. (B,C) The RRP and the SRP
sizes and the sustained phase are significantly reduced in cells ex-
pressing SybII-C103N in comparison to wild-type cells expression.
(D) The burst phase of the capacitance trace is scaled to 0.5 s after
stimulus.(*P<0.05, **P<0.01 ***P<0.001, Student’s t-test ).
[Fig. 6.3 B,C]. Unlike the kinetics of vesicles fusion mediated by the mutations
that inhibit dimerization, SybII-C103N which increase dimerization in invitro,
slowed down the fusion of the burst phase of exocytosis, as observed after scal-
ing the capacitance amplitudes [Fig.6.3 D].
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Table 6.1: Exponential fit parameters of the capacitance trace.
Dimerization
Mutations
RRP (fF) τRRP(ms) SRP(fF) τSRP(s) Sust.
Phase (fF)
Dimer-
ization
(%)
SybII 66.9±13.8 17.7±2.2 42.5±9.4 0.18±0.03 92.9±
20.01
SybII-L99A 44.4±16.7 20.9±7.6 31.4±4.8 0.2±0.06 33.7± 7.8 ∼ 49± 12.5
[10]
SybII-
L99A/I111A
27.3±7.2 16.5±4.5 36.1±10.1 0.2±0.04 22.6±5.2
SybII-L99A/
C103A/I111A
10±1.4 13.8±3.2 29.1±6.4 0.2±0.06 21.2± 1.2 ∼ 30 ± 10
[10]
SybII 59.9±15.7 16.2±4.5 57.9±14.6 0.20±0.07 93.9±
21.01
100
SybII-C103N 7.4±1.9 21.9±7.0 20.1±4.5 0.24±0.04 30.3±4.82 1400±600
[4]
6.4 Discussion
The dimerization of the TMD of synaptobrevin-2 has been controversial be-
cause invitro studies have yielded inconsistent conclusions [4, 10, 11]. Here
we examined the physiological relevance of synaptobrevin-2 transmembrane
mutants that have been linked to its TMD dimerization invitro. We have ob-
served that the single point mutation SybII-I111A and the double point muta-
tion SybII-L99A/C103A partially rescued exocytosis when they are expressed in
DKO embryonic chromaffin cells. This result is in agreement with ∼50% reduc-
tion of dimerization-to-monomer ratios obtained invitro [10]. Conversely, the
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triple point mutation SybII-L99A/C103A/I111A nearly abolishes vesicle secre-
tion, consistent with significant reduction of dimerization previously reported
[10]. Our data strongly correlates the inhibition of exocytosis by these mutants
with their impairment of dimerization, thus suggesting that synaptobrevin-2
dimerization is an intermediate step in exocytosis.
The SNARE complex ”zipped” from the N- to the C-terminal [17]. This
assembly follows a two steps process where the N-terminal assembles during
priming, followed by a calcium dependent C-terminal association [24, 17, 19].
Our mutations slow down vesicles priming while keeping the fusion rate con-
stant. This can be explained by the fact that the dimerization mutants interfere
with the assembly of the N-terminal assembly of the SNARE complex. Further-
more, the kinetic of fusion was not affected by these mutants, suggesting that
synaptobrevin-2 dimerization is not important for the triggering of exocytosis.
Computation studies have shown that synaptobrevin-2 transmembrane
domains are at closest at position C103 [8]. We mutated C103 to asparagine
because this alteration was reported to increase SybII TMD-TMD interaction.
Here we have shown that the expression of this mutant in chromaffin cells, also
inhibits the vesicles priming and slows down fast vesicles fusion. This can be
explained by the fact that asparagine is polar amino acid, thus its position in
the lipid bilayers is not favorable and is likely to change the protein/lipid dy-
namic. This is not unexpected since in Chapter III, and V, we have reported the
inhibition of exocytosis by charged residues in the transmembrane domain of
synaptobrevin-2.
The importance of synaptobrevin-2 dimerization is not yet fully under-
stood, however, it is speculated that the multimerization of the SNAREs facil-
itates the release of neurotransmitters [5, 2, 21]. However, the exact number
of SNARE complexes required for single vesicle fusion is still subject of debate
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(review [13]). If multiple SNARE complexes were required to facilitate vesicle
fusion, synaptobrevin-2 dimerization could stabilize this super SNARE complex
structure. However, here we have found that increasing the interaction between
synaptobrevin-2 also inhibit vesicles fusion.
Thus alternatively, we envision a scenario in which, similarly to syntaxin
forming clusters [16], synaptobrevin-2 would also form clusters. A synaptobrevin-
2 cluster would result from the interaction of multiple synaptobrevin-2 trans-
membrane domains. The role of this cluster could be to act as a reservoir to
facilitate the availability of synaptobrevin-2 in participating in the SNARE com-
plex formation. It is possible that our mutations render the cluster too tight
(increase in dimerization) or too lose (decrease in dimerization), both states
unfavorable for vesicles priming. To achieve vesicle priming, synaptobrevin-
2 on the vesicle needs to find a way to bind to SNAP-25 and syntaxin on the
plasma membrane. This step could be mediated by an accessory protein whose
main function will be to direct synaptobrevin-2 from the cluster site to its target
complex. We propose that this accessory protein could potentially be synapto-
physin. Similar to synaptobrevin-2, synaptophysin is embedded into the vesicle
via a transmembrane region, and it has been determined that synaptobrevin-2
forms an hetero structure with synaptophysin [14, 1], and this interaction is
mediated by their transmembrane domains interaction. When a toxin is used
to cleave synaptobrevin-2, synaptophysin can still bind to its C-terminal trans-
membrane region (residues 68-116) [27]. Interestingly, synaptophysin can only
bind one synaptobrevin-2 [1] and when this composite structure is formed,
synaptobrevin-2 can no longer interact with either syntaxin or SNAP-25. There-
fore, it is possible that synaptophysin recruits synaptobrevin from the cluster via
TMD-TMD interaction and retains it until the pre-complex formed by syntaxin-
SNAP-25 is achieved [7]. In so doing protein recognition is be facilitated as well
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as the achievement of vesicle priming and fast vesicle fusion.
6.5 Method.
The high resolution calcium flash photolysis data were collected as previously
described (Chapter III) The chromaffin cells were isolated from E17-E19 mice
and were cultured for 2 to 3 days. The infection of cells were typically car-
ried for 4 to 5 hours using Semliki Forest Virus expression system. During the
recording of the traces, the cells bathed in saline solution containing (mM): 145
NaCl, 2.8 KCl, 2 CaCl2, 1 MgCl2, and 10 Hepes plus 2 mg/ml D-glucose, pH
7.2. To stimulate exocytosis, the cells were infused with intra cellular solution
containing (mM ): 100 Cs-glutamate, 4 CaCl2, 32 Hepes, 2 Mg-ATP, 0.3 GTP, 1
ascorbic acid, 5 nitrophenyl-EGTA, 0.4 fura-4F, and 0.4 furaptra, pH 7.2. For
the capacitance analysis, each trace was fitted with the sum of three exponential
functions:
f (x) = A0 + A1(1 − exp[−t/τ1]) + A2(1 − exp[−t/τ2]) + A3(1 − exp[−t/τ3]),
where A0 is the capacitance of the whole-cell membrane before the stimulus,
A1,A2 τ1 and τ2 are the amplitude and time constant of the RRP and SRP, respec-
tively. The parameters A3 and τ3 were not considered because this component
consist of a mixture of exocytosis and endocytosis [23, 18]. The values reported
are mean ± s.e.m. and the student’s t-test was used to determine the statistical
significance (*P<0.05, **P<0.01 ***P<0.001)
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CHAPTER 7
CONCLUSIONS
Exocytosis is definitely a fascinating subject, by studying this process we
can decipher not only how information is transmitted from neurons to neurons,
but also how other secretory cells discard their contents into the extracellular
space.
Katz and Del Castillo in 1956 postulated the existence of membrane pack-
ets containing neurotransmitters, from a simple drawing showing membrane
packets approaching a cell membrane and releasing their molecules into the
extracellular space, they gave birth to the idea of neuronal exocytosis. The
existence of these membrane packets or vesicles were later confirmed by elec-
tron micrography. Today, not only we know that several cell types encompass
vesicles, but we also know that the fusion of these vesicles with the cell mem-
brane depends not only on calcium but also on the so-called SNARE proteins.
When neurons or neuroendocrine cells are infused with toxins that cleave these
SNARE proteins, exocytosis is abolished. Furthermore, we know that for a vesi-
cle to fuse with the plasma membrane, it has to reach a maturation state also
called priming, it has to dock with the cell plasma membrane, and a fusion pore
has to be created to allow the diffusion of neurotransmitters into the extracellu-
lar space.
Although the Sørensen group have identified the role of SNARE proteins
in vesicle priming and docking, it was still unclear whether the SNARE proteins
are also involved in the fusion pore formation. Based on experimental evidences
described in Chapter III, we have established that the transmembrane domain of
SNARE protein synaptobrevin-2 disrupts the vesicular lipid bilayer continuity
to initiate the fusion pore formation. We have also speculated that the cell lipid
bilayer could also be disrupt with the movement of the transmembrane domain
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of syntaxin, however this should be confirmed in future experiments.
Synapto-pHluorin is protein that has been extensively used in optical mea-
surements of exocytosis because it is pH sensitive, which means that when
Synapto-pHluorin is in an acidic environment, the fluorescence of the pHluo-
rin on the protein is quenched. However, when the pH value exceeds 7.2 the
fluorescence is dequenched. Hence synapto-pHluorin has been used to monitor
the fusion of vesicles with the plasma membrane. The interior of the vesicle has
a pH of 5.6 thus, when synapto-pHluorin is located on the vesicles, it appears
dark under a fluorescence microscope. When the vesicles fuse with the plasma
membrane, synapto-pHluorin is now exposed to the cytoplasm (pH 7.2), and
there it brightened. However, synapto-pHluorin is composed of pH sensitive
GFP protein or pHluorin attached to the C-terminal end of the synaptobrevin-
2 protein. Our data in Chapter III indicate that when extra amino acids are
added at the C-terminal end of synaptobrevin-2, the protein partially loses its
functionality. Thus, it was important to assess whether synapto-pHluorin was
functional in mediating exocytosis. We find that in general, synapto-pHluorin
mediates vesicle exocytosis but not to full level, as it hinders the priming and
the fast fusion of vesicles with the cell plasma membrane. However, exocytosis
is not inhibited when synapto-pHluorin is in the presence of synaptobrevin-2.
Overall this means that synapto-pHluorin is better used as an optical tool to vi-
sualize the process of exocytoisis however care should be taken when using it
to assess the kinetic of exocytosis.
Even though the concept of multiple SNARE protein interaction is widely
accepted, such as in the case of the SNARE protein syntaxin, whose self interac-
tion leads to syntaxin clusters, the idea of synaptobrevin interactions has been
disputed. In Chapter VI we have explored whether the amino acids at the cen-
ter of synaptobrevin-2 TMD-TMD dimerization in vitro also hold in cells. We
110
find that the mutations that inhibited synaptobrevin dimerization in-vitro also
inhibit calcium dependent exocytosis in cells. Hence, base on functional simi-
larities between synaptobrevin and syntaxin, we postulate that synaptobrevin-2
may also form clusters. However, it remains to be established experimentally
the existence of these clusters and to define their role.
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